<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE collection SYSTEM "BioC.dtd">
<collection><source>PMC</source><date>20201222</date><key>pmc.key</key><document><id>6027196</id><infon key="license">CC BY</infon><passage><infon key="article-id_doi">10.3390/ph11020057</infon><infon key="article-id_pmc">6027196</infon><infon key="article-id_pmid">29874824</infon><infon key="article-id_publisher-id">pharmaceuticals-11-00057</infon><infon key="elocation-id">57</infon><infon key="issue">2</infon><infon key="kwd">computational drug repositioning drug repositioning drug repurposing machine learning deep learning crowdsourcing open innovation drug discovery</infon><infon key="license">Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).</infon><infon key="name_0">surname:Yella;given-names:Jaswanth K.</infon><infon key="name_1">surname:Yaddanapudi;given-names:Suryanarayana</infon><infon key="name_2">surname:Wang;given-names:Yunguan</infon><infon key="name_3">surname:Jegga;given-names:Anil G.</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">11</infon><infon key="year">2018</infon><offset>0</offset><text>Changing Trends in Computational Drug Repositioning</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>52</offset><text>Efforts to maximize the indications potential and revenue from drugs that are already marketed are largely motivated by what Sir James Black, a Nobel Prize-winning pharmacologist advocated—“The most fruitful basis for the discovery of a new drug is to start with an old drug”. However, rational design of drug mixtures poses formidable challenges because of the lack of or limited information about in vivo cell regulation, mechanisms of genetic pathway activation, and in vivo pathway interactions. Hence, most of the successfully repositioned drugs are the result of “serendipity”, discovered during late phase clinical studies of unexpected but beneficial findings. The connections between drug candidates and their potential adverse drug reactions or new applications are often difficult to foresee because the underlying mechanism associating them is largely unknown, complex, or dispersed and buried in silos of information. Discovery of such multi-domain pharmacomodules—pharmacologically relevant sub-networks of biomolecules and/or pathways—from collection of databases by independent/simultaneous mining of multiple datasets is an active area of research. Here, while presenting some of the promising bioinformatics approaches and pipelines, we summarize and discuss the current and evolving landscape of computational drug repositioning.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1415</offset><text>1. Introduction</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1431</offset><text>The path to new drug discovery has always been a road full of twists and turns. De novo drug discovery in particular is an expensive, time-consuming, and high risk process. For instance, the total average cost of developing a new drug, as per an estimate, ranges from $2 billion to $3 billion and it takes at least 13–15 years to bring a drug to the market—starting from initial discovery to the approval stage. Further, the process suffers from a high rate of attrition. About 10% of the drugs that enter into clinical trials get approved by regulatory agencies. The remaining 90% of the drugs fail due to inefficacy or high toxicity due to the limited predictive value of preclinical studies. Nearly 62% of the compounds fail in Phase II and approximately 45% attrition occurs in Phase III. These attritions are due to insufficient R&amp;D productivity in identifying the drug response on the target due to the limited availability of preclinical disease models which has raised concerns in the pharmaceutical industry. Despite rapid technological advances and exponential increases in pharmaceutical R&amp;D investments, the number of newly approved drugs continues to be the same. To overcome these challenges and to potentially bypass this productivity gap, more and more companies are resorting to “drug repositioning” or “drug repurposing” (sometimes also referred to as drug reprofiling, drug retasking, or therapeutic switching) or simply identifying and developing new therapeutic uses for existing or abandoned pharmacotherapies. The premise is that since most approved compounds have known bioavailability and safety profiles, proven formulation and manufacturing routes, and reasonably characterized pharmacology, repositioned drugs can enter clinical phases more rapidly and at a lower cost than novel compounds. Further, the 90% therapeutic development failure rate means there are many existing, partially developed therapeutic candidates that could be re-visited, explored further, and potentially repurposed for a new disease, common or rare. It is therefore not surprising that in recent years, of the new drugs that reach their first markets, repositioned drugs have taken up to a percentage of ~30%! For instance, of the 113 new drugs and biologics approved or launched in 2017, only seven were first-in-class agents (an approved and launched first drug with a novel mechanism of action) while 36 were repositioned drugs. As per an estimate, this bypassing can potentially make a drug available for use in patients within 3–12 years with a total estimated cost of $40–80 million.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>4040</offset><text>Most of the successful cases of drug repurposing have been serendipitous discoveries rather than systematic, hypothesis-driven outcomes. These include the accidental discovery of thalidomide as an agent for leprosy or the more notable example of sildenafil, an angina medication developed in 1989 subsequently marketed as Viagra®, a blockbuster drug to treat erectile dysfunction (see Table 1 for additional examples of drug repositioning). De novo drug therapies for more than 8000 orphan or rare diseases are impossible to develop with the current R&amp;D costs, however, drug repositioning with its premise of discovering hidden connections or building connections between a drug and disease hold promise for orphan disease therapy. Further, revisiting the approved drugs for identifying new indications helps the pharmaceutical companies to extend the patent life of drugs, through application to adjacent diseases and also helps the company to protect the IP against competitors.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5022</offset><text>In-silico methods like data-mining, machine learning, and network-based approaches, offer an unprecedented opportunity to predict all possible drug repositioning candidates using available diverse and heterogeneous data sources from genomics and biomedical domains. Indeed, predictive models have been built using these methods exploiting existing data such as protein targets, chemical structure, or phenotypic information such as profiles of side-effect, gene expression, etc. While the advances in computational sciences bring the possibility of applying novel algorithms and approaches to systems biology data, these datasets themselves have triggered fundamental research on more complex problems. As a result of this hybrid approach of utilizing computational methods and experimental screenings, various modalities of drug repositioning methods have emerged. Computational drug repositioning methods focus on shared characteristics between two drugs and depending on what kind of drug discovery (drug-based or disease-based), the methods can be classified in to target-based, expression-based, knowledge-based, chemical structure-based, pathway-based and mechanism of action-based. In this review article, we briefly outline the recent progress in computational methods and strategies applied on the drug-disease data for drug repositioning investigations.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>6386</offset><text>2. Approaches</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6400</offset><text>In silico drug repurposing challenges that are drug-centric (i.e., discovering new indications for existing drugs) or disease-centric (i.e., identifying an effective drug as a potential treatment for disease) have the common challenge of either assessing the similarity or connections between drugs or between diseases. Jin and Wong reviewed a variety of approaches used as a basis for computational drug repurposing. These can be broadly categorized as knowledge-based and signature-based approaches.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>6902</offset><text>2.1. Knowledge-Based Drug Repurposing</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6940</offset><text>This repurposing method utilizes the available information on drug such as drug-targets, chemical structures, adverse effects, pathways etc. and builds computational models to predict unknown mechanisms, targets or new bio-markers for diseases. In pathway-based approach, signaling pathways, metabolic pathways and protein-interaction networks data are used to compute the similarity or connections between drug and disease. The processed omics data, for example, from human patients or animal models of disease are used to reconstruct disease-specific pathways that can serve as key targets for novel therapeutic discovery or for repositioned drugs. Target mechanism-based approaches on the other hand take into account known mechanism of action and target role : Here, the data available on signaling pathways, protein interactions and omics data are integrated to identify the potential mechanism of action (MoA) of drugs. This in turn can enable find better and even specific drug targets and also for discover of an alternate medication for any disease.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>7999</offset><text>2.2. Signature-Based Drug Repurposing</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8037</offset><text>This method makes use of gene expression signatures by comparing drug gene expression profiles and disease gene expression profiles and is frequently referred to as ‘signature reversion’ method. Gene expression based methods are effective in constructing a detailed map of connections between diseases and drug actions.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>8361</offset><text>Connectivity Map (CMap), NCBI’s Gene Expression (GEO), and the relatively recent LINCS datasets are also extensively explored in drug repositioning studies. Recent technical and technological advancements in molecular biology and exponential growth of biomedical data while presenting challenges have also opened up an array of opportunities to develop and apply novel and powerful computational approaches that can enable informed drug repositioning. The free availability of data repositories are further directing and catalyzing these efforts. In Table 2 we present some of the widely used open source drug- and disease-centric and related databases. These include, for instance, databases that provide information on the known targets, mechanism of action, gene expression, clinical status, ADMET properties, signaling pathways and disease-centric database which has omics data (transcriptomic, proteomic, genetic characteristics of diseases).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>9311</offset><text>2.3. In Silico Methods for Drug Repositioning</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9357</offset><text>In the following sections, we present an overview of some of the in silico methods—current and emerging—used for facilitating drug repositioning candidate discovery.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_3</infon><offset>9527</offset><text>2.3.1. Machine Learning</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>9551</offset><text>Any machine learning workflow typically comprises of 4 steps: data pre-processing, feature extraction, model fitting and evaluation. PREDICT, is a similarity based machine learning framework, integrating drug-drug similarity (based on drug-protein interactions, sequence and gene-ontology) and disease-disease similarity (disease-phenotype and human phenotype ontology) where the authors have used them as features applying logistic regression to predict similar drugs for similar diseases and they achieved AUC = 0.9 in predicting drug indications. SPACE, another similarity-based method predicts anatomical therapeutic chemical classification of drugs by integrating multiple data sources using Logistic Regression. Likewise, several such similarity based methods have been reported for predicting novel drug indications.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>10375</offset><text>Deep learning, a large class of machine learning-based models composed of multiple processing layers representing data with a high level of abstraction are now being explored computational biology field for a wide-variety of applications including drug discovery. The principal difference between conventional “shallow” learning (neural network with one or two hidden layers) and deep learning is that while the former does not deal with raw data and requires a feature extraction step to be performed before the learning process, the latter not only discovers intricate structure in large data sets but by using the backpropagation algorithm allows changing the internal parameters incrementally to compute the representation in each layer from the representation in the previous layer. Deep learning-based approaches have dramatically improved the state-of-the-art in speech recognition, visual object recognition, object detection and are currently being explored in biomedical and genomic domains. Aliper and Plis, for example, used deep learning with gene expression data to learn drug therapeutic categories and found that deep neural networks surpassed SVM after 10 fold cross validation suggesting a working proof for applying deep learning for drug discovery and development. Interestingly, Zhao and Cheong, compared deep neural networks (DNN) approach with SVM-based approach to predict psychiatric drug indications based on the expression profiles of drugs and reported that. While more studies are needed to understand if DNN-based approaches indeed have the claimed benefits, there have been additional reports suggesting that deep learning-based approaches perform better than traditional machine learning algorithms in toxicity prediction by enabling multi-task learning.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_3</infon><offset>12166</offset><text>2.3.2. Network Models</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>12188</offset><text>Network-based approaches have been extensively exploited in computational drug repositioning for identifying novel drug targets, interactions, and indications. Typically, in these models, the nodes in the networks represent either drug, disease, or gene products and edges represent the interactions or relationships between them. These networks are either knowledge-based or computationally inferred using multiple data resources and have various representations such as drug-drug, drug-target, drug-disease, disease-disease, disease-gene, disease-drug, protein-protein interactions, and transcriptional networks. Cheng and Liu computed similarities—drug-based, target-based, and network-based—to predict drug-target interaction in a bi-partite network and found that network based inference method performed best with an average ROC AUC of 0.96. Similar homogenous or bipartite network models have been incorporated using phenotype data such as side-effect, transcriptional, drug-disease and signaling pathway data.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>13210</offset><text>Integrating heterogeneous data also provides diverse information and has the potential to unveil hidden or unknown drug-disease relationships based on the guilt-by-association principle. Most of the similarity-based methods are either drug-centric or disease-centric networks, with relatively few approaches that built a drug-disease heterogeneous network using compendia of gene annotations and network clustering to identify drug repositioning candidates. Luo and Zhao, built a similar network-based framework using heterogeneous data through a network diffusion process and used the diffusion distributions to derive the prediction scores of drug-target interactions. Recently, Himmelstein et al. integrated data from 29 public resources to identify dug repositioning candidates and predicted the probability of repositioning for 209,168 drug-disease pairs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_3</infon><offset>14071</offset><text>2.3.3. Mining Electronic Health Records for Drug Repurposing</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>14132</offset><text>Electronic health records (EHR) of the patients which provide medications details along with patient history can also be mined to identify drug repositioning candidates. Applying natural language processing on EHRs, for instance, reveals post-market, additional adverse drug events which are not found in clinical trials. These side-effects information can be potentially used for drug-repositioning and validation. Mining EHR records for example helped in identifying that metformin, a most commonly prescribed medication for type II diabetes, can also be repurposed for cancer treatment. The relevance and accuracy of the model’s prediction needs to be assessed in discovering a drug whose indications are unknown. The validity of novel drug prediction can be evaluated by comparing the predicted targets in ClinicalTrials.gov, PubMed abstracts or EHR records. The performance of the model can be evaluated by computing area under the ROC curve (AUC ROC) and Precision Recall (PR) curve. Sensitivity is a metric to measure the proportion of true positive identified correctly and Specificity is the proportion of negatives correctly identified as negatives. Due to the large unannotated drug-indication pairs as false positives, the sensitivity and specificity estimates are poor and creates substantial imbalance of true positives and true negatives. In a recent review, Brown and Patel suggest that using sensitivity-validation alone is ideal since it does not need the true negatives. The authors further suggest that investigators should test their model performance with cross-validation to prevent over-fitting and weak predictive performance.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>15786</offset><text>2.4. Open Innovation—Crowd Sourcing</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>15824</offset><text>Crowd sourcing is a collaborative approach of delegating tasks to the crowd where the variety of expertise available generates new insights or hypothesis with the available data. This paradigm has been taken advantage in a multitude areas from diverse domains including health care and genomics. The open source drug discovery process enables faster translation of research to results with a clear definition on specific problem, task decomposition and immediate feedback loop. Pharmaceutical companies, due to the limitations in R&amp;D business model and man power often are focused on specific diseases which may or may not include rare and neglected diseases. Hence, few pharmaceutical and non-profit companies have used crowdsourcing platforms and embraced a wide-variety of innovative solutions directing towards discussing the scientific enigmas. Several open innovation platforms have been established in order to build industry-academia partnerships and to explore science and business opportunities with mutual benefit (Table 3).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_3</infon><offset>16860</offset><text>National Center for Advancing Translational Sciences (NCATS)—NIH-Academia-Industry Partnerships Initiative</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>16969</offset><text>The National Institutes of Health (NIH), as part of the new therapeutic uses program, launched (i) NCATS’ NIH-Industry Partnerships initiative in 2012 to foster collaboration between pharmaceutical companies and the biomedical research community; and (ii) bench-to clinical repurposing initiative to test the utility of crowdsourcing efforts or computational approaches for drug repurposing.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>17363</offset><text>The focus of the match-making NIH-industry partnerships projects is to match researchers with open assets from pharmaceutical assets to fuel and accelerate drug repurposing candidate discovery. Through this initiative, NCATS supports and advances research on a wide range of common and rare (including neglected) diseases. Current industry partners in this initiative include: AstraZeneca, AbbVie, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Janssen Pharmaceuticals, MedImmune, Mereo BioPharma, Pfizer, and Sanofi. The participating companies make a number of partially developed assets available to academic researchers to crowdsource repurposing ideas. Projects using most of these assets can go directly into Phase II clinical trials, while some may require additional pre-clinical investigations or a Phase I clinical trial (e.g., testing in target populations to determine dosing, assess safety and tolerability).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>18288</offset><text>Through the bench-to-clinic repurposing program, NCATS supports pre-clinical studies, clinical feasibility studies or proof-of-concept clinical trials to assess the utility of computational approaches or crowdsourcing efforts in discovering drug repurposing candidates. Table 4 lists the new therapeutic uses projects funded by NIH-NCATS through these two programs (additional details can be found at ).</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_2</infon><offset>18692</offset><text>2.5. Open Source Software</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>18718</offset><text>The open source movement has created a substantial value in pursuing towards “state-of-the-art” research over the last decade with the help of reusable and generic software libraries for data processing. Jupyter Notebook for instance is the modern data analysis tool for reproducible computational research that supports open source languages like Python, Julia, C++, R and several other languages and provides rich features for interactive computing, visualization, and documentation. Structured data tools like Scikit-learn, R-Programming, Orange and Weka are useful for mining, analysis, learning and statistical computing. For the high dimensional un-structured data such as images, text, or audio outputs, deep learning tools like TensorFlow, Keras, PyTorch, CNTK, and Matlab that take advantage of multi-GPU accelerated training are increasingly used. Gephi and Cytoscape are other popular tools used primarily for bimolecular interaction networks, omics-data integration, clustering and visualization. In Table 5, we summarize few such used tools used in computational drug discovery and repositioning.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">title_1</infon><offset>19832</offset><text>3. Discussion</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>19846</offset><text>Drug repositioning acts as a viable strategy for a cost-effective de novo drug discovery. Although in silico methods have proven to be successful in addressing the problem of repurposing, some challenges continue to be addressed. One of the principal issues is the missing drug-disease indication data. Marking the missing indications as true negatives or ignoring them from training can potentially compromise the predictive power of the computational model for drug repurposing candidate discovery. Second, the lack of a true gold standard dataset for drug repositioning makes it difficult for in silico methods to evaluate results. As a result, common performance metrics such as sensitivity, specificity, and precision are used to assess the utility of computational drug repurposing algorithms. Third, existing computational methods tend to be predominantly one-sided (e.g., drug-centric or disease-centric). However, the integration of multi-omic data with similarity measures have been shown to have better predictive performance with identification of novel therapeutic compounds.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>20935</offset><text>The sea of biomedical information (see Table 2), in which small molecule and gene/protein structural, functional and process knowledge—both in normal and disease states—is embedded consists of unstructured free-text as in publications and structured or semi-structured relational databases. Transforming information from these silos into actionable knowledge is facilitated by establishing connectivity among the subsets taken from these multiple heterogeneous and diverse domains. For example, a pharmacomodule consisting of a group of genes, biological processes, pathways, phenotypes, small molecules (approved drugs or investigational compounds), and a group of drug-induced or related adverse events forms a meaningful multi-domain module when the interdependency among most of the pairs of subsets are supported by scientific evidence (literature or databases). These pharmacomodules can potentially take us closer to answering the how question about the underlying a hypothetical mechanism of action or phenomena. An informed answer to the how question holds the premise to generate better and informed drug repositioning hypotheses. Growing scientific evidence suggests that any compound found to be safe in humans is likely to have multiple therapeutic uses. However, almost all successful drug reposition crossovers so far have been the result of either accidental occurrences or informed guesses. Given that this “back-to-basics” approach for repositioning is growing in popularity, there is an urgent need for more efficient and systematic computational approaches to first systematize the available genomic and pharmacological databases for representation and knowledge discovery and then use these databases and pattern discovery tools to identify the potential new uses for existing drugs. What is needed clearly is a paradigm shift in the approaches—genomic, biopharmacological, and computational—for a more informed systematic drug rediscovery (“systematic serendipity”) taking into account all of the data resources. Originally coined by Eugene Garfield, “systematic serendipity” refers to the organized process of discovering previously unknown scientific relations using citation databases, leading to better possibilities for a collaboration of human serendipity with computer supported knowledge discovery.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>23284</offset><text>The credibility of published research will improve the discoveries in science if the provided compendium has an evidence for the accuracy and reproducibility of the results. Reproducibility particularly is a major issue especially when scientific papers publish unexpected, positive results and other researchers or an independent research group is unable to replicate the same results even after using same or similar methods as reported by the original study. It has been estimated that the irreproducible research costs up to $28 billion per year! Providing the code and data used to obtain the claimed and reported results is always a better strategy than mere describing them in natural language in the paper and can be eventually an incremental step towards a better science. The recent Findability, Accessibility, Interoperability, Reusability (FAIR) data principles go beyond the mere reuse of data by individuals but rather enhance the ability of machines to support and find and use the data automatically. These include any efforts that support discovery and reproducibility through good data management practices such as good data management, maintenance of the data flow, and sharing relevant tools or pipelines used in the research. The recent Datasets2Tools project is in compliance with these principles and enables users to search for contributed canned analyses, datasets and tools. Computational science research can be replicated effectively using tools like code version control software like Github and transferable computational environments like Docker. Over the past few years, the reproducibility issue is being taken seriously and many journals insist on providing code and data when submitting the paper.</text></passage><passage><infon key="section_type">DISCUSS</infon><infon key="type">paragraph</infon><offset>25017</offset><text>In summary, emerging and advanced novel computational methods and crowdsourcing-based approaches that enable the joint analysis of genomic, biomedical and pharmacological data hold the premise to facilitate informed, efficient, and systematic drug repositioning. Whether this premise expedites drug development pipelines and how much of it translates into novel therapeutic discovery and impacts public health, especially catering to unmet needs (e.g., rare and neglected diseases), positively remains to be seen.</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">title</infon><offset>25531</offset><text>Author Contributions</text></passage><passage><infon key="section_type">AUTH_CONT</infon><infon key="type">paragraph</infon><offset>25552</offset><text>J.K.Y. and A.G.J. conceived the outline, reviewed the literature and wrote the manuscript; S.Y. and Y.W. participated in the discussions and provided the edits to some sections of the paper.</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">title</infon><offset>25743</offset><text>Conflicts of Interest</text></passage><passage><infon key="section_type">COMP_INT</infon><infon key="type">paragraph</infon><offset>25765</offset><text>The authors declare no conflict of interest.</text></passage><passage><infon key="section_type">REF</infon><infon key="type">title</infon><offset>25810</offset><text>References</text></passage><passage><infon key="fpage">191</infon><infon key="lpage">200</infon><infon key="name_0">surname:Scannell;given-names:J.W.</infon><infon key="name_1">surname:Blanckley;given-names:A.</infon><infon key="name_2">surname:Boldon;given-names:H.</infon><infon key="name_3">surname:Warrington;given-names:B.</infon><infon key="pub-id_pmid">22378269</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2012</infon><offset>25821</offset><text>Diagnosing the decline in pharmaceutical R&amp;D efficiency</text></passage><passage><infon key="fpage">151</infon><infon key="name_0">surname:Akhondzadeh;given-names:S.</infon><infon key="pub-id_pmid">27920881</infon><infon key="section_type">REF</infon><infon key="source">Avicenna J. Med. Biotechnol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2016</infon><offset>25877</offset><text>The Importance of Clinical Trials in Drug Development</text></passage><passage><infon key="fpage">581</infon><infon key="lpage">594</infon><infon key="name_0">surname:Plenge;given-names:R.M.</infon><infon key="name_1">surname:Scolnick;given-names:E.M.</infon><infon key="name_2">surname:Altshuler;given-names:D.</infon><infon key="pub-id_doi">10.1038/nrd4051</infon><infon key="pub-id_pmid">23868113</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2013</infon><offset>25931</offset><text>Validating therapeutic targets through human genetics</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">5</infon><infon key="name_0">surname:Kola;given-names:I.</infon><infon key="name_1">surname:Landis;given-names:J.</infon><infon key="pub-id_doi">10.1038/nrd1470</infon><infon key="pub-id_pmid">15286737</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>25985</offset><text>Can the pharmaceutical industry reduce attrition rates?</text></passage><passage><infon key="fpage">203</infon><infon key="lpage">214</infon><infon key="name_0">surname:Paul;given-names:S.M.</infon><infon key="name_1">surname:Mytelka;given-names:D.S.</infon><infon key="name_2">surname:Dunwiddie;given-names:C.T.</infon><infon key="name_3">surname:Persinger;given-names:C.C.</infon><infon key="name_4">surname:Munos;given-names:B.H.</infon><infon key="name_5">surname:Lindborg;given-names:S.R.</infon><infon key="name_6">surname:Schacht;given-names:A.L.</infon><infon key="pub-id_doi">10.1038/nrd3078</infon><infon key="pub-id_pmid">20168317</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2010</infon><offset>26041</offset><text>How to improve RD productivity: The pharmaceutical industry’s grand challenge</text></passage><passage><infon key="fpage">451</infon><infon key="lpage">456</infon><infon key="name_0">surname:Booth;given-names:B.</infon><infon key="name_1">surname:Zemmel;given-names:R.</infon><infon key="pub-id_doi">10.1038/nrd1384</infon><infon key="pub-id_pmid">15136792</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>26121</offset><text>Opinion/Outlook: Prospects for productivity</text></passage><passage><infon key="fpage">673</infon><infon key="lpage">683</infon><infon key="name_0">surname:Ashburn;given-names:T.T.</infon><infon key="name_1">surname:Thor;given-names:K.B.</infon><infon key="pub-id_doi">10.1038/nrd1468</infon><infon key="pub-id_pmid">15286734</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2004</infon><offset>26165</offset><text>Drug repositioning: Identifying and developing new uses for existing drugs</text></passage><passage><infon key="fpage">51</infon><infon key="lpage">100</infon><infon key="name_0">surname:Graul;given-names:A.I.</infon><infon key="name_1">surname:Cruces;given-names:E.</infon><infon key="name_2">surname:Stringer;given-names:M.</infon><infon key="pub-id_pmid">24524105</infon><infon key="section_type">REF</infon><infon key="source">Drugs of Today</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2014</infon><offset>26240</offset><text>The year’s new drugs &amp; biologics, 2013: Part I</text></passage><passage><infon key="fpage">335</infon><infon key="lpage">341</infon><infon key="name_0">surname:Hurle;given-names:M.R.</infon><infon key="name_1">surname:Yang;given-names:L.</infon><infon key="name_2">surname:Xie;given-names:Q.</infon><infon key="name_3">surname:Rajpal;given-names:D.K.</infon><infon key="name_4">surname:Sanseau;given-names:P.</infon><infon key="name_5">surname:Agarwal;given-names:P.</infon><infon key="pub-id_doi">10.1038/clpt.2013.1</infon><infon key="pub-id_pmid">23443757</infon><infon key="section_type">REF</infon><infon key="source">Clin. Pharmacol. Ther.</infon><infon key="type">ref</infon><infon key="volume">93</infon><infon key="year">2013</infon><offset>26289</offset><text>Computational drug repositioning: From data to therapeutics</text></passage><passage><infon key="fpage">2016</infon><infon key="lpage">2018</infon><infon key="name_0">surname:Papapetropoulos;given-names:A.</infon><infon key="name_1">surname:Szabo;given-names:C.</infon><infon key="pub-id_doi">10.1111/bph.14081</infon><infon key="pub-id_pmid">29313889</infon><infon key="section_type">REF</infon><infon key="source">Br. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="year">2018</infon><offset>26349</offset><text>Inventing new therapies without reinventing the wheel: The power of drug repurposing</text></passage><passage><infon key="fpage">153</infon><infon key="lpage">160</infon><infon key="name_0">surname:Padhy;given-names:B.M.</infon><infon key="name_1">surname:Gupta;given-names:Y.K.</infon><infon key="pub-id_doi">10.4103/0022-3859.81870</infon><infon key="pub-id_pmid">21654146</infon><infon key="section_type">REF</infon><infon key="source">J. Postgrad. Med.</infon><infon key="type">ref</infon><infon key="volume">57</infon><infon key="year">2011</infon><offset>26434</offset><text>Drug repositioning: Re-investigating existing drugs for new therapeutic indications</text></passage><passage><infon key="fpage">314</infon><infon key="lpage">316</infon><infon key="name_0">surname:Nosengo;given-names:N.</infon><infon key="pub-id_doi">10.1038/534314a</infon><infon key="pub-id_pmid">27306171</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">534</infon><infon key="year">2016</infon><offset>26518</offset><text>Can you teach old drugs new tricks?</text></passage><passage><infon key="fpage">346</infon><infon key="lpage">356</infon><infon key="name_0">surname:Sardana;given-names:D.</infon><infon key="name_1">surname:Zhu;given-names:C.</infon><infon key="name_2">surname:Zhang;given-names:M.</infon><infon key="name_3">surname:Gudivada;given-names:R.C.</infon><infon key="name_4">surname:Yang;given-names:L.</infon><infon key="name_5">surname:Jegga;given-names:A.G.</infon><infon key="pub-id_doi">10.1093/bib/bbr021</infon><infon key="pub-id_pmid">21504985</infon><infon key="section_type">REF</infon><infon key="source">Brief. Bioinform.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2011</infon><offset>26554</offset><text>Drug repositioning for orphan diseases</text></passage><passage><infon key="name_0">surname:Cha;given-names:Y.</infon><infon key="name_1">surname:Erez;given-names:T.</infon><infon key="name_2">surname:Reynolds;given-names:I.J.</infon><infon key="name_3">surname:Kumar;given-names:D.</infon><infon key="name_4">surname:Ross;given-names:J.</infon><infon key="name_5">surname:Koytiger;given-names:G.</infon><infon key="name_6">surname:Kusko;given-names:R.</infon><infon key="name_7">surname:Zeskind;given-names:B.</infon><infon key="name_8">surname:Risso;given-names:S.</infon><infon key="name_9">surname:Kagan;given-names:E.</infon><infon key="pub-id_doi">10.1111/bph.13798</infon><infon key="pub-id_pmid">28369768</infon><infon key="section_type">REF</infon><infon key="source">Br. J. Pharmacol.</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>26593</offset><text>Drug repurposing from the perspective of pharmaceutical companies</text></passage><passage><infon key="fpage">2</infon><infon key="lpage">12</infon><infon key="name_0">surname:Li;given-names:J.</infon><infon key="name_1">surname:Zheng;given-names:S.</infon><infon key="name_2">surname:Chen;given-names:B.</infon><infon key="name_3">surname:Butte;given-names:A.J.</infon><infon key="name_4">surname:Swamidass;given-names:S.J.</infon><infon key="name_5">surname:Lu;given-names:Z.</infon><infon key="pub-id_doi">10.1093/bib/bbv020</infon><infon key="pub-id_pmid">25832646</infon><infon key="section_type">REF</infon><infon key="source">Brief. Bioinform.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2016</infon><offset>26659</offset><text>A survey of current trends in computational drug repositioning</text></passage><passage><infon key="fpage">1009</infon><infon key="lpage">1025</infon><infon key="name_0">surname:Prathipati;given-names:P.</infon><infon key="name_1">surname:Mizuguchi;given-names:K.</infon><infon key="pub-id_doi">10.2174/1568026615666150826114524</infon><infon key="section_type">REF</infon><infon key="source">Curr. Top. Med. Chem.</infon><infon key="type">ref</infon><infon key="volume">16</infon><infon key="year">2015</infon><offset>26722</offset><text>Systems Biology Approaches to a Rational Drug Discovery Paradigm</text></passage><passage><infon key="fpage">27</infon><infon key="name_0">surname:Li;given-names:Y.Y.</infon><infon key="name_1">surname:Jones;given-names:S.J.M.</infon><infon key="pub-id_pmid">22494857</infon><infon key="section_type">REF</infon><infon key="source">Genome Med.</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2012</infon><offset>26787</offset><text>Drug repositioning for personalized medicine</text></passage><passage><infon key="fpage">637</infon><infon key="lpage">644</infon><infon key="name_0">surname:Jin;given-names:G.</infon><infon key="name_1">surname:Wong;given-names:S.T.C.</infon><infon key="pub-id_doi">10.1016/j.drudis.2013.11.005</infon><infon key="pub-id_pmid">24239728</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2014</infon><offset>26832</offset><text>Toward better drug repositioning: Prioritizing and integrating existing methods into efficient pipelines</text></passage><passage><infon key="fpage">110</infon><infon key="lpage">115</infon><infon key="name_0">surname:Liu;given-names:Z.</infon><infon key="name_1">surname:Fang;given-names:H.</infon><infon key="name_2">surname:Reagan;given-names:K.</infon><infon key="name_3">surname:Xu;given-names:X.</infon><infon key="name_4">surname:Mendrick;given-names:D.L.</infon><infon key="name_5">surname:Slikker;given-names:W.</infon><infon key="name_6">surname:Tong;given-names:W.</infon><infon key="pub-id_doi">10.1016/j.drudis.2012.08.005</infon><infon key="pub-id_pmid">22935104</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2013</infon><offset>26937</offset><text>In silico drug repositioning: What we need to know</text></passage><passage><infon key="name_0">surname:Emig;given-names:D.</infon><infon key="name_1">surname:Ivliev;given-names:A.</infon><infon key="name_2">surname:Pustovalova;given-names:O.</infon><infon key="name_3">surname:Lancashire;given-names:L.</infon><infon key="name_4">surname:Bureeva;given-names:S.</infon><infon key="name_5">surname:Nikolsky;given-names:Y.</infon><infon key="name_6">surname:Bessarabova;given-names:M.</infon><infon key="pub-id_doi">10.1371/journal.pone.0060618</infon><infon key="pub-id_pmid">23593264</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2013</infon><offset>26988</offset><text>Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach</text></passage><passage><infon key="name_0">surname:Cheng;given-names:F.</infon><infon key="name_1">surname:Liu;given-names:C.</infon><infon key="name_2">surname:Jiang;given-names:J.</infon><infon key="name_3">surname:Lu;given-names:W.</infon><infon key="name_4">surname:Li;given-names:W.</infon><infon key="name_5">surname:Liu;given-names:G.</infon><infon key="name_6">surname:Zhou;given-names:W.</infon><infon key="name_7">surname:Huang;given-names:J.</infon><infon key="name_8">surname:Tang;given-names:Y.</infon><infon key="pub-id_doi">10.1371/journal.pcbi.1002503</infon><infon key="pub-id_pmid">22589709</infon><infon key="section_type">REF</infon><infon key="source">PLoS Comput. Biol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2012</infon><offset>27072</offset><text>Prediction of drug-target interactions and drug repositioning via network-based inference</text></passage><passage><infon key="name_0">surname:Zhao;given-names:S.</infon><infon key="name_1">surname:Li;given-names:S.</infon><infon key="pub-id_doi">10.1371/journal.pone.0011764</infon><infon key="pub-id_pmid">20668676</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2010</infon><offset>27162</offset><text>Network-based relating pharmacological and genomic spaces for drug target identification</text></passage><passage><infon key="name_0">surname:Yang;given-names:L.</infon><infon key="name_1">surname:Agarwal;given-names:P.</infon><infon key="pub-id_doi">10.1371/journal.pone.0028025</infon><infon key="pub-id_pmid">22205936</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2011</infon><offset>27251</offset><text>Systematic drug repositioning based on clinical side-effects</text></passage><passage><infon key="name_0">surname:Kinnings;given-names:S.L.</infon><infon key="name_1">surname:Liu;given-names:N.</infon><infon key="name_2">surname:Buchmeier;given-names:N.</infon><infon key="name_3">surname:Tonge;given-names:P.J.</infon><infon key="name_4">surname:Xie;given-names:L.</infon><infon key="name_5">surname:Bourne;given-names:P.E.</infon><infon key="pub-id_doi">10.1371/journal.pcbi.1000423</infon><infon key="pub-id_pmid">19578428</infon><infon key="section_type">REF</infon><infon key="source">PLoS Comput. Biol.</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2009</infon><offset>27312</offset><text>Drug discovery using chemical systems biology: Repositioning the safe medicine Comtan to treat multi-drug and extensively drug resistant tuberculosis</text></passage><passage><infon key="name_0">surname:Jadamba;given-names:E.</infon><infon key="name_1">surname:Shin;given-names:M.</infon><infon key="pub-id_doi">10.1155/2016/7147039</infon><infon key="pub-id_pmid">28127549</infon><infon key="section_type">REF</infon><infon key="source">BioMed Res. Int.</infon><infon key="type">ref</infon><infon key="volume">2016</infon><infon key="year">2016</infon><offset>27462</offset><text>A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network</text></passage><passage><infon key="name_0">surname:Li;given-names:J.</infon><infon key="name_1">surname:Lu;given-names:Z.</infon><infon key="pub-id_doi">10.1186/1471-2105-14-S16-S3</infon><infon key="pub-id_pmid">24564553</infon><infon key="section_type">REF</infon><infon key="source">BMC Bioinform.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2013</infon><offset>27585</offset><text>Pathway-based drug repositioning using causal inference</text></passage><passage><infon key="fpage">593</infon><infon key="lpage">606</infon><infon key="name_0">surname:Kotelnikova;given-names:E.</infon><infon key="name_1">surname:Yuryev;given-names:A.</infon><infon key="name_2">surname:Mazo;given-names:I.</infon><infon key="name_3">surname:Daraselia;given-names:N.</infon><infon key="pub-id_doi">10.1142/S0219720010004732</infon><infon key="pub-id_pmid">20556864</infon><infon key="section_type">REF</infon><infon key="source">J. Bioinform. Comput. Biol.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2010</infon><offset>27641</offset><text>Computational approaches for drug repositioning and combination therapy design</text></passage><passage><infon key="fpage">1503</infon><infon key="lpage">1506</infon><infon key="name_0">surname:Cramer;given-names:P.</infon><infon key="name_1">surname:Cirrito;given-names:J.</infon><infon key="name_2">surname:Wesson;given-names:D.</infon><infon key="pub-id_doi">10.1126/science.1217697</infon><infon key="pub-id_pmid">22323736</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">335</infon><infon key="year">2012</infon><offset>27720</offset><text>ApoE-Directed Therapeutics Rapidly Clear beta-Amyloid and Reverse Deficits in AD Mouse Models</text></passage><passage><infon key="fpage">269</infon><infon key="lpage">277</infon><infon key="name_0">surname:Sivachenko;given-names:A.</infon><infon key="name_1">surname:Kalinin;given-names:A.</infon><infon key="name_2">surname:Yuryev;given-names:A.</infon><infon key="pub-id_doi">10.2174/157016306780368117</infon><infon key="pub-id_pmid">17430103</infon><infon key="section_type">REF</infon><infon key="source">Curr. Drug Discov. Technol.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2006</infon><offset>27814</offset><text>Pathway Analysis for Design of Promiscuous Drugs and Selective Drug Mixtures</text></passage><passage><infon key="fpage">1447</infon><infon key="lpage">1448</infon><infon key="name_0">surname:Strittmatter;given-names:W.J.</infon><infon key="pub-id_doi">10.1126/science.1220725</infon><infon key="pub-id_pmid">22442467</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">335</infon><infon key="year">2012</infon><offset>27891</offset><text>Old drug, new hope for Alzheimer’s disease</text></passage><passage><infon key="name_0">surname:Jin;given-names:G.</infon><infon key="name_1">surname:Zhao;given-names:H.</infon><infon key="name_2">surname:Zhou;given-names:X.</infon><infon key="name_3">surname:Wong;given-names:S.T.C.</infon><infon key="pub-id_doi">10.1093/bioinformatics/btr202</infon><infon key="pub-id_pmid">21685086</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">2011</infon><offset>27936</offset><text>An enhanced Petri-Net model to predict synergistic effects of pairwise drug combinations from gene microarray data</text></passage><passage><infon key="fpage">33</infon><infon key="lpage">44</infon><infon key="name_0">surname:Jin;given-names:G.</infon><infon key="name_1">surname:Fu;given-names:C.</infon><infon key="name_2">surname:Zhao;given-names:H.</infon><infon key="name_3">surname:Cui;given-names:K.</infon><infon key="name_4">surname:Chang;given-names:J.</infon><infon key="name_5">surname:Wong;given-names:S.T.C.</infon><infon key="pub-id_doi">10.1158/0008-5472.CAN-11-2333</infon><infon key="pub-id_pmid">22108825</infon><infon key="section_type">REF</infon><infon key="source">Cancer Res.</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">2012</infon><offset>28051</offset><text>A novel method of transcriptional response analysis to facilitate drug repositioning for cancer therapy</text></passage><passage><infon key="name_0">surname:Iskar;given-names:M.</infon><infon key="name_1">surname:Zeller;given-names:G.</infon><infon key="name_2">surname:Blattmann;given-names:P.</infon><infon key="name_3">surname:Campillos;given-names:M.</infon><infon key="name_4">surname:Kuhn;given-names:M.</infon><infon key="name_5">surname:Kaminska;given-names:K.H.</infon><infon key="name_6">surname:Runz;given-names:H.</infon><infon key="name_7">surname:Gavin;given-names:A.C.</infon><infon key="name_8">surname:Pepperkok;given-names:R.</infon><infon key="name_9">surname:Van Noort;given-names:V.</infon><infon key="pub-id_doi">10.1038/msb.2013.20</infon><infon key="pub-id_pmid">23632384</infon><infon key="section_type">REF</infon><infon key="source">Mol. Syst. Biol.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2013</infon><offset>28155</offset><text>Characterization of drug-induced transcriptional modules: Towards drug repositioning and functional understanding</text></passage><passage><infon key="fpage">13</infon><infon key="lpage">24</infon><infon key="name_0">surname:Gaiteri;given-names:C.</infon><infon key="name_1">surname:Ding;given-names:Y.</infon><infon key="name_2">surname:French;given-names:B.</infon><infon key="name_3">surname:Tseng;given-names:G.C.</infon><infon key="name_4">surname:Sibille;given-names:E.</infon><infon key="pub-id_doi">10.1111/gbb.12106</infon><infon key="pub-id_pmid">24320616</infon><infon key="section_type">REF</infon><infon key="source">Genes Brain Behav.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2014</infon><offset>28269</offset><text>Beyond modules and hubs: The potential of gene coexpression networks for investigating molecular mechanisms of complex brain disorders</text></passage><passage><infon key="fpage">350</infon><infon key="lpage">357</infon><infon key="name_0">surname:Iorio;given-names:F.</infon><infon key="name_1">surname:Rittman;given-names:T.</infon><infon key="name_2">surname:Ge;given-names:H.</infon><infon key="name_3">surname:Menden;given-names:M.</infon><infon key="name_4">surname:Saez-Rodriguez;given-names:J.</infon><infon key="pub-id_doi">10.1016/j.drudis.2012.07.014</infon><infon key="pub-id_pmid">22897878</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2013</infon><offset>28404</offset><text>Transcriptional data: A new gateway to drug repositioning?</text></passage><passage><infon key="fpage">96ra77</infon><infon key="name_0">surname:Sirota;given-names:M.</infon><infon key="name_1">surname:Dudley;given-names:J.T.</infon><infon key="name_2">surname:Kim;given-names:J.</infon><infon key="name_3">surname:Chiang;given-names:A.P.</infon><infon key="name_4">surname:Morgan;given-names:A.A.</infon><infon key="name_5">surname:Sweet-Cordero;given-names:A.</infon><infon key="name_6">surname:Sage;given-names:J.</infon><infon key="name_7">surname:Butte;given-names:A.J.</infon><infon key="pub-id_doi">10.1126/scitranslmed.3001318</infon><infon key="pub-id_pmid">21849665</infon><infon key="section_type">REF</infon><infon key="source">Sci. Transl. Med.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2011</infon><offset>28463</offset><text>Discovery and preclinical validation of drug indications using compendia of public gene expression data (Science Translational Medicine (2011) 3, (102er))</text></passage><passage><infon key="name_0">surname:Zhao;given-names:K.</infon><infon key="name_1">surname:So;given-names:H.-C.</infon><infon key="pub-id_arxiv">1706.03014</infon><infon key="section_type">REF</infon><infon key="source">arXiv</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>28618</offset><text>A machine learning approach to drug repositioning based on drug expression profiles: Applications in psychiatry</text></passage><passage><infon key="name_0">surname:Wang;given-names:Y.</infon><infon key="name_1">surname:Yella;given-names:J.</infon><infon key="name_2">surname:Chen;given-names:J.</infon><infon key="name_3">surname:McCormack;given-names:F.X.</infon><infon key="name_4">surname:Madala;given-names:S.K.</infon><infon key="name_5">surname:Jegga;given-names:A.G.</infon><infon key="pub-id_doi">10.1186/s12890-017-0472-9</infon><infon key="pub-id_pmid">29058630</infon><infon key="section_type">REF</infon><infon key="source">BMC Pulm. Med.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2017</infon><offset>28730</offset><text>Unsupervised gene expression analyses identify IPF-severity correlated signatures, associated genes and biomarkers</text></passage><passage><infon key="elocation-id">e24662</infon><infon key="name_0">surname:Claerhout;given-names:S.</infon><infon key="name_1">surname:Lim;given-names:J.Y.</infon><infon key="name_2">surname:Choi;given-names:W.</infon><infon key="name_3">surname:Park;given-names:Y.-Y.</infon><infon key="name_4">surname:Kim;given-names:K.</infon><infon key="name_5">surname:Kim;given-names:S.-B.</infon><infon key="name_6">surname:Lee;given-names:J.-S.</infon><infon key="name_7">surname:Mills;given-names:G.B.</infon><infon key="name_8">surname:Cho;given-names:J.Y.</infon><infon key="pub-id_doi">10.1371/journal.pone.0024662</infon><infon key="pub-id_pmid">21931799</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2011</infon><offset>28845</offset><text>Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer</text></passage><passage><infon key="name_0">surname:Chang;given-names:M.</infon><infon key="name_1">surname:Smith;given-names:S.</infon><infon key="name_2">surname:Thorpe;given-names:A.</infon><infon key="name_3">surname:Barratt;given-names:M.J.</infon><infon key="name_4">surname:Karim;given-names:F.</infon><infon key="pub-id_doi">10.1186/1744-8069-6-56</infon><infon key="pub-id_pmid">20846436</infon><infon key="section_type">REF</infon><infon key="source">Mol. Pain</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2010</infon><offset>28944</offset><text>Evaluation of phenoxybenzamine in the CFA model of pain following gene expression studies and connectivity mapping</text></passage><passage><infon key="fpage">D907</infon><infon key="lpage">D913</infon><infon key="name_0">surname:Cai;given-names:M.C.</infon><infon key="name_1">surname:Xu;given-names:Q.</infon><infon key="name_2">surname:Pan;given-names:Y.J.</infon><infon key="name_3">surname:Pan;given-names:W.</infon><infon key="name_4">surname:Ji;given-names:N.</infon><infon key="name_5">surname:Li;given-names:Y.B.</infon><infon key="name_6">surname:Liu;given-names:H.J.J.K.</infon><infon key="name_7">surname:Ji;given-names:Z.L.</infon><infon key="pub-id_doi">10.1093/nar/gku1066</infon><infon key="pub-id_pmid">25361966</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2015</infon><offset>29059</offset><text>ADReCS: An ontology database for aiding standardization and hierarchical Classification of adverse drug reaction terms</text></passage><passage><infon key="name_0">surname:Gaulton;given-names:A.</infon><infon key="name_1">surname:Bellis;given-names:L.J.</infon><infon key="name_2">surname:Bento;given-names:A.P.</infon><infon key="name_3">surname:Chambers;given-names:J.</infon><infon key="name_4">surname:Davies;given-names:M.</infon><infon key="name_5">surname:Hersey;given-names:A.</infon><infon key="name_6">surname:Light;given-names:Y.</infon><infon key="name_7">surname:McGlinchey;given-names:S.</infon><infon key="name_8">surname:Michalovich;given-names:D.</infon><infon key="name_9">surname:Al-Lazikani;given-names:B.</infon><infon key="pub-id_doi">10.1093/nar/gkr777</infon><infon key="pub-id_pmid">21948594</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2012</infon><offset>29178</offset><text>ChEMBL: A large-scale bioactivity database for drug discovery</text></passage><passage><infon key="fpage">502</infon><infon key="lpage">506</infon><infon key="name_0">surname:Williams;given-names:A.J.</infon><infon key="pub-id_doi">10.1016/j.drudis.2008.03.015</infon><infon key="pub-id_pmid">18549976</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2008</infon><offset>29240</offset><text>Internet-based tools for communication and collaboration in chemistry</text></passage><passage><infon key="fpage">1437</infon><infon key="lpage">1452</infon><infon key="name_0">surname:Subramanian;given-names:A.</infon><infon key="name_1">surname:Narayan;given-names:R.</infon><infon key="name_2">surname:Corsello;given-names:S.M.</infon><infon key="name_3">surname:Peck;given-names:D.D.</infon><infon key="name_4">surname:Natoli;given-names:T.E.</infon><infon key="name_5">surname:Lu;given-names:X.</infon><infon key="name_6">surname:Gould;given-names:J.</infon><infon key="name_7">surname:Davis;given-names:J.F.</infon><infon key="name_8">surname:Tubelli;given-names:A.A.</infon><infon key="name_9">surname:Asiedu;given-names:J.K.</infon><infon key="pub-id_doi">10.1016/j.cell.2017.10.049</infon><infon key="pub-id_pmid">29195078</infon><infon key="section_type">REF</infon><infon key="source">Cell</infon><infon key="type">ref</infon><infon key="volume">171</infon><infon key="year">2017</infon><offset>29310</offset><text>A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles</text></passage><passage><infon key="fpage">793</infon><infon key="name_0">surname:Mattingly;given-names:C.J.</infon><infon key="name_1">surname:Colby;given-names:G.T.</infon><infon key="name_2">surname:Forrest;given-names:J.N.</infon><infon key="name_3">surname:Boyer;given-names:J.L.</infon><infon key="pub-id_doi">10.1289/ehp.6028</infon><infon key="pub-id_pmid">12760826</infon><infon key="section_type">REF</infon><infon key="source">Environ. Health Perspect.</infon><infon key="type">ref</infon><infon key="volume">111</infon><infon key="year">2003</infon><offset>29394</offset><text>The Comparative Toxicogenomics Database (CTD)</text></passage><passage><infon key="comment">Available online: http://dailymed.nlm.nih.gov/dailymed/index.cfm</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>29440</offset><text>National Institutes of Health: Health &amp; Human Services DailyMed</text></passage><passage><infon key="fpage">1209</infon><infon key="lpage">1210</infon><infon key="name_0">surname:Griffith;given-names:M.</infon><infon key="name_1">surname:Griffith;given-names:O.L.</infon><infon key="name_2">surname:Coffman;given-names:A.C.</infon><infon key="name_3">surname:Weible;given-names:J.V.</infon><infon key="name_4">surname:Mcmichael;given-names:J.F.</infon><infon key="name_5">surname:Spies;given-names:N.C.</infon><infon key="name_6">surname:Koval;given-names:J.</infon><infon key="name_7">surname:Das;given-names:I.</infon><infon key="name_8">surname:Callaway;given-names:M.B.</infon><infon key="name_9">surname:Eldred;given-names:J.M.</infon><infon key="pub-id_doi">10.1038/nmeth.2689</infon><infon key="pub-id_pmid">24122041</infon><infon key="section_type">REF</infon><infon key="source">Nat. Methods</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">2013</infon><offset>29504</offset><text>DGIdb: Mining the druggable genome</text></passage><passage><infon key="comment">Available online: http://www.drugbank.ca</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>29539</offset><text>DrugBank DrugBank</text></passage><passage><infon key="fpage">D932</infon><infon key="lpage">D939</infon><infon key="name_0">surname:Ursu;given-names:O.</infon><infon key="name_1">surname:Holmes;given-names:J.</infon><infon key="name_2">surname:Knockel;given-names:J.</infon><infon key="name_3">surname:Bologa;given-names:C.G.</infon><infon key="name_4">surname:Yang;given-names:J.J.</infon><infon key="name_5">surname:Mathias;given-names:S.L.</infon><infon key="name_6">surname:Nelson;given-names:S.J.</infon><infon key="name_7">surname:Oprea;given-names:T.I.</infon><infon key="pub-id_doi">10.1093/nar/gkw993</infon><infon key="pub-id_pmid">27789690</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2017</infon><offset>29557</offset><text>DrugCentral: Online drug compendium</text></passage><passage><infon key="fpage">1540</infon><infon key="lpage">1541</infon><infon key="name_0">surname:Pihan;given-names:E.</infon><infon key="name_1">surname:Colliandre;given-names:L.</infon><infon key="name_2">surname:Guichou;given-names:J.F.</infon><infon key="name_3">surname:Douguet;given-names:D.</infon><infon key="pub-id_doi">10.1093/bioinformatics/bts186</infon><infon key="pub-id_pmid">22539672</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2012</infon><offset>29593</offset><text>E-Drug3D: 3D structure collections dedicated to drug repurposing and fragment-based drug design</text></passage><passage><infon key="name_0">surname:Yang;given-names:W.</infon><infon key="name_1">surname:Soares;given-names:J.</infon><infon key="name_2">surname:Greninger;given-names:P.</infon><infon key="name_3">surname:Edelman;given-names:E.J.</infon><infon key="name_4">surname:Lightfoot;given-names:H.</infon><infon key="name_5">surname:Forbes;given-names:S.</infon><infon key="name_6">surname:Bindal;given-names:N.</infon><infon key="name_7">surname:Beare;given-names:D.</infon><infon key="name_8">surname:Smith;given-names:J.A.</infon><infon key="name_9">surname:Thompson;given-names:I.R.</infon><infon key="pub-id_doi">10.1093/nar/gks1111</infon><infon key="pub-id_pmid">23180760</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2013</infon><offset>29689</offset><text>Genomics of Drug Sensitivity in Cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells</text></passage><passage><infon key="fpage">D985</infon><infon key="lpage">D994</infon><infon key="name_0">surname:Koscielny;given-names:G.</infon><infon key="name_1">surname:An;given-names:P.</infon><infon key="name_2">surname:Carvalho-Silva;given-names:D.</infon><infon key="name_3">surname:Cham;given-names:J.A.</infon><infon key="name_4">surname:Fumis;given-names:L.</infon><infon key="name_5">surname:Gasparyan;given-names:R.</infon><infon key="name_6">surname:Hasan;given-names:S.</infon><infon key="name_7">surname:Karamanis;given-names:N.</infon><infon key="name_8">surname:Maguire;given-names:M.</infon><infon key="name_9">surname:Papa;given-names:E.</infon><infon key="pub-id_doi">10.1093/nar/gkw1055</infon><infon key="pub-id_pmid">27899665</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2017</infon><offset>29799</offset><text>Open Targets: A platform for therapeutic target identification and Validation</text></passage><passage><infon key="fpage">163</infon><infon key="lpage">165</infon><infon key="name_0">surname:Hewett;given-names:M.</infon><infon key="name_1">surname:Oliver;given-names:D.E.</infon><infon key="name_2">surname:Rubin;given-names:D.L.</infon><infon key="name_3">surname:Easton;given-names:K.L.</infon><infon key="name_4">surname:Stuart;given-names:J.M.</infon><infon key="name_5">surname:Altman;given-names:R.B.</infon><infon key="name_6">surname:Klein;given-names:T.E.</infon><infon key="pub-id_doi">10.1093/nar/30.1.163</infon><infon key="pub-id_pmid">11752281</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2002</infon><offset>29877</offset><text>PharmGKB: The pharmacogenetics knowledge base</text></passage><passage><infon key="fpage">4066</infon><infon key="lpage">4072</infon><infon key="name_0">surname:Pires;given-names:D.E.V.</infon><infon key="name_1">surname:Blundell;given-names:T.L.</infon><infon key="name_2">surname:Ascher;given-names:D.B.</infon><infon key="pub-id_doi">10.1021/acs.jmedchem.5b00104</infon><infon key="pub-id_pmid">25860834</infon><infon key="section_type">REF</infon><infon key="source">J. Med. Chem.</infon><infon key="type">ref</infon><infon key="volume">58</infon><infon key="year">2015</infon><offset>29923</offset><text>pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures</text></passage><passage><infon key="name_0">surname:Cowley;given-names:G.S.</infon><infon key="name_1">surname:Weir;given-names:B.A.</infon><infon key="name_2">surname:Vazquez;given-names:F.</infon><infon key="name_3">surname:Tamayo;given-names:P.</infon><infon key="name_4">surname:Scott;given-names:J.A.</infon><infon key="name_5">surname:Rusin;given-names:S.</infon><infon key="name_6">surname:East-Seletsky;given-names:A.</infon><infon key="name_7">surname:Ali;given-names:L.D.</infon><infon key="name_8">surname:Gerath;given-names:W.F.J.</infon><infon key="name_9">surname:Pantel;given-names:S.E.</infon><infon key="pub-id_doi">10.1038/sdata.2014.35</infon><infon key="pub-id_pmid">25984343</infon><infon key="section_type">REF</infon><infon key="source">Sci. Data</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2014</infon><offset>30025</offset><text>Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies</text></passage><passage><infon key="name_0">surname:Von Eichborn;given-names:J.</infon><infon key="name_1">surname:Murgueitio;given-names:M.S.</infon><infon key="name_2">surname:Dunkel;given-names:M.</infon><infon key="name_3">surname:Koerner;given-names:S.</infon><infon key="name_4">surname:Bourne;given-names:P.E.</infon><infon key="name_5">surname:Preissner;given-names:R.</infon><infon key="pub-id_doi">10.1093/nar/gkq1037</infon><infon key="pub-id_pmid">21071407</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2011</infon><offset>30161</offset><text>PROMISCUOUS: A database for network-based drug-repositioning</text></passage><passage><infon key="fpage">D1202</infon><infon key="lpage">D1213</infon><infon key="name_0">surname:Kim;given-names:S.</infon><infon key="name_1">surname:Thiessen;given-names:P.A.</infon><infon key="name_2">surname:Bolton;given-names:E.E.</infon><infon key="name_3">surname:Chen;given-names:J.</infon><infon key="name_4">surname:Fu;given-names:G.</infon><infon key="name_5">surname:Gindulyte;given-names:A.</infon><infon key="name_6">surname:Han;given-names:L.</infon><infon key="name_7">surname:He;given-names:J.</infon><infon key="name_8">surname:He;given-names:S.</infon><infon key="name_9">surname:Shoemaker;given-names:B.A.</infon><infon key="pub-id_doi">10.1093/nar/gkv951</infon><infon key="pub-id_pmid">26400175</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">2016</infon><offset>30222</offset><text>PubChem substance and compound databases</text></passage><passage><infon key="fpage">D1075</infon><infon key="lpage">D1079</infon><infon key="name_0">surname:Kuhn;given-names:M.</infon><infon key="name_1">surname:Letunic;given-names:I.</infon><infon key="name_2">surname:Jensen;given-names:L.J.</infon><infon key="name_3">surname:Bork;given-names:P.</infon><infon key="pub-id_doi">10.1093/nar/gkv1075</infon><infon key="pub-id_pmid">26481350</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">2016</infon><offset>30263</offset><text>The SIDER database of drugs and side effects</text></passage><passage><infon key="name_0">surname:Kuhn;given-names:M.</infon><infon key="name_1">surname:von Mering;given-names:C.</infon><infon key="name_2">surname:Campillos;given-names:M.</infon><infon key="name_3">surname:Jensen;given-names:L.J.</infon><infon key="name_4">surname:Bork;given-names:P.</infon><infon key="pub-id_doi">10.1093/nar/gkm795</infon><infon key="pub-id_pmid">18084021</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2008</infon><offset>30308</offset><text>STITCH: Interaction networks of chemicals and proteins</text></passage><passage><infon key="name_0">surname:Dunkel;given-names:M.</infon><infon key="name_1">surname:Günther;given-names:S.</infon><infon key="name_2">surname:Ahmed;given-names:J.</infon><infon key="name_3">surname:Wittig;given-names:B.</infon><infon key="name_4">surname:Preissner;given-names:R.</infon><infon key="pub-id_doi">10.1093/nar/gkn307</infon><infon key="pub-id_pmid">18499712</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">36</infon><infon key="year">2008</infon><offset>30363</offset><text>SuperPred: Drug classification and target prediction</text></passage><passage><infon key="fpage">412</infon><infon key="lpage">415</infon><infon key="name_0">surname:Chen;given-names:X.</infon><infon key="name_1">surname:Ji;given-names:Z.L.</infon><infon key="name_2">surname:Chen;given-names:Y.Z.</infon><infon key="pub-id_doi">10.1093/nar/30.1.412</infon><infon key="pub-id_pmid">11752352</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2002</infon><offset>30416</offset><text>TTD: Therapeutic Target Database</text></passage><passage><infon key="fpage">D928</infon><infon key="lpage">D934</infon><infon key="name_0">surname:Wishart;given-names:D.</infon><infon key="name_1">surname:Arndt;given-names:D.</infon><infon key="name_2">surname:Pon;given-names:A.</infon><infon key="name_3">surname:Sajed;given-names:T.</infon><infon key="name_4">surname:Guo;given-names:A.C.</infon><infon key="name_5">surname:Djoumbou;given-names:Y.</infon><infon key="name_6">surname:Knox;given-names:C.</infon><infon key="name_7">surname:Wilson;given-names:M.</infon><infon key="name_8">surname:Liang;given-names:Y.</infon><infon key="name_9">surname:Grant;given-names:J.</infon><infon key="pub-id_doi">10.1093/nar/gku1004</infon><infon key="pub-id_pmid">25378312</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2015</infon><offset>30449</offset><text>T3DB: The toxic exposome database</text></passage><passage><infon key="fpage">1260419</infon><infon key="name_0">surname:Uhlén;given-names:M.</infon><infon key="name_1">surname:Fagerberg;given-names:L.</infon><infon key="name_2">surname:Hallström;given-names:B.M.</infon><infon key="name_3">surname:Lindskog;given-names:C.</infon><infon key="name_4">surname:Oksvold;given-names:P.</infon><infon key="name_5">surname:Mardinoglu;given-names:A.</infon><infon key="name_6">surname:Sivertsson;given-names:Å.</infon><infon key="name_7">surname:Kampf;given-names:C.</infon><infon key="name_8">surname:Sjöstedt;given-names:E.</infon><infon key="name_9">surname:Asplund;given-names:A.</infon><infon key="pub-id_doi">10.1126/science.1260419</infon><infon key="pub-id_pmid">25613900</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">347</infon><infon key="year">2015</infon><offset>30483</offset><text>Proteomics. Tissue-based map of the human proteome</text></passage><passage><infon key="fpage">29</infon><infon key="lpage">34</infon><infon key="name_0">surname:Ogata;given-names:H.</infon><infon key="name_1">surname:Goto;given-names:S.</infon><infon key="name_2">surname:Sato;given-names:K.</infon><infon key="name_3">surname:Fujibuchi;given-names:W.</infon><infon key="name_4">surname:Bono;given-names:H.</infon><infon key="name_5">surname:Kanehisa;given-names:M.</infon><infon key="pub-id_doi">10.1093/nar/27.1.29</infon><infon key="pub-id_pmid">9847135</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">27</infon><infon key="year">1999</infon><offset>30534</offset><text>KEGG: Kyoto encyclopedia of genes and genomes</text></passage><passage><infon key="fpage">1707</infon><infon key="lpage">1712</infon><infon key="name_0">surname:Akbarian;given-names:S.</infon><infon key="name_1">surname:Liu;given-names:C.</infon><infon key="name_2">surname:Knowles;given-names:J.A.</infon><infon key="name_3">surname:Vaccarino;given-names:F.M.</infon><infon key="name_4">surname:Farnham;given-names:P.J.</infon><infon key="name_5">surname:Crawford;given-names:G.E.</infon><infon key="name_6">surname:Jaffe;given-names:A.E.</infon><infon key="name_7">surname:Pinto;given-names:D.</infon><infon key="name_8">surname:Dracheva;given-names:S.</infon><infon key="name_9">surname:Geschwind;given-names:D.H.</infon><infon key="pub-id_doi">10.1038/nn.4156</infon><infon key="pub-id_pmid">26605881</infon><infon key="section_type">REF</infon><infon key="source">Nat. Neurosci.</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2015</infon><offset>30580</offset><text>The PsychENCODE project</text></passage><passage><infon key="fpage">D996</infon><infon key="lpage">D1008</infon><infon key="name_0">surname:Sunkin;given-names:S.M.</infon><infon key="name_1">surname:Ng;given-names:L.</infon><infon key="name_2">surname:Lau;given-names:C.</infon><infon key="name_3">surname:Dolbeare;given-names:T.</infon><infon key="name_4">surname:Gilbert;given-names:T.L.</infon><infon key="name_5">surname:Thompson;given-names:C.L.</infon><infon key="name_6">surname:Hawrylycz;given-names:M.</infon><infon key="name_7">surname:Dang;given-names:C.</infon><infon key="pub-id_doi">10.1093/nar/gks1042</infon><infon key="pub-id_pmid">23193282</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2013</infon><offset>30604</offset><text>Allen Brain Atlas: An integrated spatio-temporal portal for exploring the central nervous system</text></passage><passage><infon key="fpage">D553</infon><infon key="lpage">D555</infon><infon key="name_0">surname:Parkinson;given-names:H.</infon><infon key="pub-id_doi">10.1093/nar/gki056</infon><infon key="pub-id_pmid">15608260</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2004</infon><offset>30701</offset><text>ArrayExpress--a public repository for microarray gene expression data at the EBI</text></passage><passage><infon key="fpage">603</infon><infon key="lpage">607</infon><infon key="name_0">surname:Barretina;given-names:J.</infon><infon key="name_1">surname:Caponigro;given-names:G.</infon><infon key="name_2">surname:Stransky;given-names:N.</infon><infon key="name_3">surname:Venkatesan;given-names:K.</infon><infon key="name_4">surname:Margolin;given-names:A.A</infon><infon key="name_5">surname:Kim;given-names:S.</infon><infon key="name_6">surname:Wilson;given-names:C.J.</infon><infon key="name_7">surname:Lehár;given-names:J.</infon><infon key="name_8">surname:Kryukov;given-names:G.V</infon><infon key="name_9">surname:Sonkin;given-names:D.</infon><infon key="pub-id_doi">10.1038/nature11003</infon><infon key="pub-id_pmid">22460905</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">483</infon><infon key="year">2012</infon><offset>30782</offset><text>The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity Supp</text></passage><passage><infon key="fpage">D805</infon><infon key="lpage">D811</infon><infon key="name_0">surname:Forbes;given-names:S.A.</infon><infon key="name_1">surname:Beare;given-names:D.</infon><infon key="name_2">surname:Gunasekaran;given-names:P.</infon><infon key="name_3">surname:Leung;given-names:K.</infon><infon key="name_4">surname:Bindal;given-names:N.</infon><infon key="name_5">surname:Boutselakis;given-names:H.</infon><infon key="name_6">surname:Ding;given-names:M.</infon><infon key="name_7">surname:Bamford;given-names:S.</infon><infon key="name_8">surname:Cole;given-names:C.</infon><infon key="name_9">surname:Ward;given-names:S.</infon><infon key="pub-id_doi">10.1093/nar/gku1075</infon><infon key="pub-id_pmid">25355519</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2015</infon><offset>30881</offset><text>COSMIC: Exploring the world’s knowledge of somatic mutations in human cancer</text></passage><passage><infon key="fpage">1181</infon><infon key="lpage">1186</infon><infon key="name_0">surname:Mailman;given-names:M.D.</infon><infon key="name_1">surname:Feolo;given-names:M.</infon><infon key="name_2">surname:Jin;given-names:Y.</infon><infon key="name_3">surname:Kimura;given-names:M.</infon><infon key="name_4">surname:Tryka;given-names:K.</infon><infon key="name_5">surname:Bagoutdinov;given-names:R.</infon><infon key="name_6">surname:Hao;given-names:L.</infon><infon key="name_7">surname:Kiang;given-names:A.</infon><infon key="name_8">surname:Paschall;given-names:J.</infon><infon key="name_9">surname:Phan;given-names:L.</infon><infon key="pub-id_doi">10.1038/ng1007-1181</infon><infon key="pub-id_pmid">17898773</infon><infon key="section_type">REF</infon><infon key="source">Nat. Genet.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2007</infon><offset>30960</offset><text>The NCBI dbGaP database of genotypes and phenotypes</text></passage><passage><infon key="fpage">308</infon><infon key="lpage">311</infon><infon key="name_0">surname:Sherry;given-names:S.T.</infon><infon key="pub-id_doi">10.1093/nar/29.1.308</infon><infon key="pub-id_pmid">11125122</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">2001</infon><offset>31012</offset><text>dbSNP: The NCBI database of genetic variation</text></passage><passage><infon key="name_0">surname:Lappalainen;given-names:I.</infon><infon key="name_1">surname:Lopez;given-names:J.</infon><infon key="name_2">surname:Skipper;given-names:L.</infon><infon key="name_3">surname:Hefferon;given-names:T.</infon><infon key="name_4">surname:Spalding;given-names:J.D.</infon><infon key="name_5">surname:Garner;given-names:J.</infon><infon key="name_6">surname:Chen;given-names:C.</infon><infon key="name_7">surname:Maguire;given-names:M.</infon><infon key="name_8">surname:Corbett;given-names:M.</infon><infon key="name_9">surname:Zhou;given-names:G.</infon><infon key="pub-id_doi">10.1093/nar/gks1213</infon><infon key="pub-id_pmid">23193291</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">41</infon><infon key="year">2013</infon><offset>31058</offset><text>DbVar and DGVa: Public archives for genomic structural variation</text></passage><passage><infon key="name_0">surname:Piñero;given-names:J.</infon><infon key="name_1">surname:Queralt-Rosinach;given-names:N.</infon><infon key="name_2">surname:Bravo;given-names:À.</infon><infon key="name_3">surname:Deu-Pons;given-names:J.</infon><infon key="name_4">surname:Bauer-Mehren;given-names:A.</infon><infon key="name_5">surname:Baron;given-names:M.</infon><infon key="name_6">surname:Sanz;given-names:F.</infon><infon key="name_7">surname:Furlong;given-names:L.I.</infon><infon key="pub-id_doi">10.1093/database/bav028</infon><infon key="pub-id_pmid">25877637</infon><infon key="section_type">REF</infon><infon key="source">Database</infon><infon key="type">ref</infon><infon key="volume">2015</infon><infon key="year">2015</infon><offset>31123</offset><text>DisGeNET: A discovery platform for the dynamical exploration of human diseases and their genes</text></passage><passage><infon key="fpage">1109</infon><infon key="lpage">1112</infon><infon key="name_0">surname:Grossman;given-names:R.L.</infon><infon key="name_1">surname:Heath;given-names:A.P.</infon><infon key="name_2">surname:Ferretti;given-names:V.</infon><infon key="name_3">surname:Varmus;given-names:H.E.</infon><infon key="name_4">surname:Lowy;given-names:D.R.</infon><infon key="name_5">surname:Kibbe;given-names:W.A.</infon><infon key="name_6">surname:Staudt;given-names:L.M.</infon><infon key="pub-id_doi">10.1056/NEJMp1607591</infon><infon key="pub-id_pmid">27653561</infon><infon key="section_type">REF</infon><infon key="source">N. Engl. J. Med.</infon><infon key="type">ref</infon><infon key="volume">375</infon><infon key="year">2016</infon><offset>31218</offset><text>Toward a Shared Vision for Cancer Genomic Data</text></passage><passage><infon key="fpage">D562</infon><infon key="lpage">D566</infon><infon key="name_0">surname:Barrett;given-names:T.</infon><infon key="pub-id_doi">10.1093/nar/gki022</infon><infon key="pub-id_pmid">15608262</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">33</infon><infon key="year">2004</infon><offset>31265</offset><text>NCBI GEO: Mining millions of expression profiles--database and tools</text></passage><passage><infon key="fpage">580</infon><infon key="lpage">585</infon><infon key="name_0">surname:Lonsdale;given-names:J.</infon><infon key="name_1">surname:Thomas;given-names:J.</infon><infon key="name_2">surname:Salvatore;given-names:M.</infon><infon key="name_3">surname:Phillips;given-names:R.</infon><infon key="name_4">surname:Lo;given-names:E.</infon><infon key="name_5">surname:Shad;given-names:S.</infon><infon key="name_6">surname:Hasz;given-names:R.</infon><infon key="name_7">surname:Walters;given-names:G.</infon><infon key="name_8">surname:Garcia;given-names:F.</infon><infon key="name_9">surname:Young;given-names:N.</infon><infon key="pub-id_doi">10.1038/ng.2653</infon><infon key="pub-id_pmid">23715323</infon><infon key="section_type">REF</infon><infon key="source">Nat. Genet.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2013</infon><offset>31334</offset><text>The Genotype-Tissue Expression (GTEx) project</text></passage><passage><infon key="fpage">575</infon><infon key="lpage">581</infon><infon key="name_0">surname:Kim;given-names:M.-S.</infon><infon key="name_1">surname:Pinto;given-names:S.M.</infon><infon key="name_2">surname:Getnet;given-names:D.</infon><infon key="name_3">surname:Nirujogi;given-names:R.S.</infon><infon key="name_4">surname:Manda;given-names:S.S.</infon><infon key="name_5">surname:Chaerkady;given-names:R.</infon><infon key="name_6">surname:Madugundu;given-names:A.K.</infon><infon key="name_7">surname:Kelkar;given-names:D.S.</infon><infon key="name_8">surname:Isserlin;given-names:R.</infon><infon key="name_9">surname:Jain;given-names:S.</infon><infon key="pub-id_doi">10.1038/nature13302</infon><infon key="pub-id_pmid">24870542</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">509</infon><infon key="year">2014</infon><offset>31380</offset><text>A draft map of the human proteome</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">20</infon><infon key="name_0">surname:Cancer;given-names:T.</infon><infon key="pub-id_doi">10.1093/database/bar026</infon><infon key="section_type">REF</infon><infon key="source">Cancer</infon><infon key="type">ref</infon><infon key="volume">2011</infon><infon key="year">2011</infon><offset>31414</offset><text>International Cancer Genome Consortium</text></passage><passage><infon key="fpage">D854</infon><infon key="lpage">D859</infon><infon key="name_0">surname:Clarke;given-names:L.</infon><infon key="name_1">surname:Fairley;given-names:S.</infon><infon key="name_2">surname:Zheng-Bradley;given-names:X.</infon><infon key="name_3">surname:Streeter;given-names:I.</infon><infon key="name_4">surname:Perry;given-names:E.</infon><infon key="name_5">surname:Lowy;given-names:E.</infon><infon key="name_6">surname:Tassé;given-names:A.M.</infon><infon key="name_7">surname:Flicek;given-names:P.</infon><infon key="pub-id_doi">10.1093/nar/gkw829</infon><infon key="pub-id_pmid">27638885</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">45</infon><infon key="year">2017</infon><offset>31453</offset><text>The international Genome sample resource (IGSR): A worldwide collection of genome variation incorporating the 1000 Genomes Project data</text></passage><passage><infon key="fpage">1477</infon><infon key="lpage">1483</infon><infon key="name_0">surname:Aymé;given-names:S.</infon><infon key="name_1">surname:Schmidtke;given-names:J.</infon><infon key="pub-id_doi">10.1007/s00103-007-0381-9</infon><infon key="pub-id_pmid">18026888</infon><infon key="section_type">REF</infon><infon key="source">Bundesgesundheitsblatt Gesundheitsforschunq Gesundheitsschutz</infon><infon key="type">ref</infon><infon key="volume">50</infon><infon key="year">2007</infon><offset>31589</offset><text>Networking for rare diseases: A necessity for Europe</text></passage><passage><infon key="fpage">1045</infon><infon key="lpage">1048</infon><infon key="name_0">surname:Bernstein;given-names:B.E.</infon><infon key="name_1">surname:Stamatoyannopoulos;given-names:J.A.</infon><infon key="name_2">surname:Costello;given-names:J.F.</infon><infon key="name_3">surname:Ren;given-names:B.</infon><infon key="name_4">surname:Milosavljevic;given-names:A.</infon><infon key="name_5">surname:Meissner;given-names:A.</infon><infon key="name_6">surname:Kellis;given-names:M.</infon><infon key="name_7">surname:Marra;given-names:M.A.</infon><infon key="name_8">surname:Beaudet;given-names:A.L.</infon><infon key="name_9">surname:Ecker;given-names:J.R.</infon><infon key="pub-id_doi">10.1038/nbt1010-1045</infon><infon key="pub-id_pmid">20944595</infon><infon key="section_type">REF</infon><infon key="source">Nat. Biotechnol.</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2010</infon><offset>31642</offset><text>The NIH roadmap epigenomics mapping consortium</text></passage><passage><infon key="name_0">surname:Szklarczyk;given-names:D.</infon><infon key="name_1">surname:Franceschini;given-names:A.</infon><infon key="name_2">surname:Kuhn;given-names:M.</infon><infon key="name_3">surname:Simonovic;given-names:M.</infon><infon key="name_4">surname:Roth;given-names:A.</infon><infon key="name_5">surname:Minguez;given-names:P.</infon><infon key="name_6">surname:Doerks;given-names:T.</infon><infon key="name_7">surname:Stark;given-names:M.</infon><infon key="name_8">surname:Muller;given-names:J.</infon><infon key="name_9">surname:Bork;given-names:P.</infon><infon key="pub-id_doi">10.1093/nar/gkq973</infon><infon key="pub-id_pmid">21045058</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">2011</infon><offset>31689</offset><text>The STRING database in 2011: Functional interaction networks of proteins, globally integrated and scored</text></passage><passage><infon key="fpage">1929</infon><infon key="lpage">1935</infon><infon key="name_0">surname:Lamb;given-names:J.</infon><infon key="name_1">surname:Crawford;given-names:E.D.</infon><infon key="name_2">surname:Peck;given-names:D.</infon><infon key="name_3">surname:Modell;given-names:J.W.</infon><infon key="name_4">surname:Blat;given-names:I.C.</infon><infon key="name_5">surname:Wrobel;given-names:M.J.</infon><infon key="name_6">surname:Lerner;given-names:J.</infon><infon key="name_7">surname:Brunet;given-names:J.P.</infon><infon key="name_8">surname:Subramanian;given-names:A.</infon><infon key="name_9">surname:Ross;given-names:K.N.</infon><infon key="pub-id_doi">10.1126/science.1132939</infon><infon key="pub-id_pmid">17008526</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">313</infon><infon key="year">2006</infon><offset>31794</offset><text>The connectivity map: Using gene-expression signatures to connect small molecules, genes, and disease</text></passage><passage><infon key="fpage">bbw112</infon><infon key="name_0">surname:Musa;given-names:A.</infon><infon key="name_1">surname:Ghoraie;given-names:L.S.</infon><infon key="name_2">surname:Zhang;given-names:S.-D.</infon><infon key="name_3">surname:Galzko;given-names:G.</infon><infon key="name_4">surname:Yli-Harja;given-names:O.</infon><infon key="name_5">surname:Dehmer;given-names:M.</infon><infon key="name_6">surname:Haibe-Kains;given-names:B.</infon><infon key="name_7">surname:Emmert-Streib;given-names:F.</infon><infon key="pub-id_doi">10.1093/bib/bbw112</infon><infon key="pub-id_pmid">28069634</infon><infon key="section_type">REF</infon><infon key="source">Brief. Bioinform.</infon><infon key="type">ref</infon><infon key="year">2017</infon><offset>31896</offset><text>A review of connectivity map and computational approaches in pharmacogenomics</text></passage><passage><infon key="fpage">878</infon><infon key="name_0">surname:Angermueller;given-names:C.</infon><infon key="name_1">surname:Pärnamaa;given-names:T.</infon><infon key="name_2">surname:Parts;given-names:L.</infon><infon key="name_3">surname:Oliver;given-names:S.</infon><infon key="pub-id_doi">10.15252/msb.20156651</infon><infon key="pub-id_pmid">27474269</infon><infon key="section_type">REF</infon><infon key="source">Mol. Syst. Biol.</infon><infon key="type">ref</infon><infon key="year">2016</infon><offset>31974</offset><text>Deep Learning for Computational Biology</text></passage><passage><infon key="name_0">surname:Gottlieb;given-names:A.</infon><infon key="name_1">surname:Stein;given-names:G.Y.</infon><infon key="name_2">surname:Ruppin;given-names:E.</infon><infon key="name_3">surname:Sharan;given-names:R.</infon><infon key="pub-id_doi">10.1038/msb.2011.26</infon><infon key="pub-id_pmid">21654673</infon><infon key="section_type">REF</infon><infon key="source">Mol. Syst. Biol.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2011</infon><offset>32014</offset><text>PREDICT: A method for inferring novel drug indications with application to personalized medicine</text></passage><passage><infon key="fpage">1788</infon><infon key="lpage">1795</infon><infon key="name_0">surname:Liu;given-names:Z.</infon><infon key="name_1">surname:Guo;given-names:F.</infon><infon key="name_2">surname:Gu;given-names:J.</infon><infon key="name_3">surname:Wang;given-names:Y.</infon><infon key="name_4">surname:Li;given-names:Y.</infon><infon key="name_5">surname:Wang;given-names:D.</infon><infon key="name_6">surname:Lu;given-names:L.</infon><infon key="name_7">surname:Li;given-names:D.</infon><infon key="name_8">surname:He;given-names:F.</infon><infon key="pub-id_doi">10.1093/bioinformatics/btv055</infon><infon key="pub-id_pmid">25638810</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2015</infon><offset>32111</offset><text>Similarity-based prediction for Anatomical Therapeutic Chemical classification of drugs by integrating multiple data sources</text></passage><passage><infon key="fpage">453</infon><infon key="lpage">456</infon><infon key="name_0">surname:Li;given-names:J.</infon><infon key="name_1">surname:Lu;given-names:Z.</infon><infon key="section_type">REF</infon><infon key="source">Proceedings of the 2012 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2012</infon><infon key="type">ref</infon><offset>32236</offset><text>A new method for computational drug repositioning using drug pairwise similarity</text></passage><passage><infon key="fpage">2664</infon><infon key="lpage">2671</infon><infon key="name_0">surname:Luo;given-names:H.</infon><infon key="name_1">surname:Wang;given-names:J.</infon><infon key="name_2">surname:Li;given-names:M.</infon><infon key="name_3">surname:Luo;given-names:J.</infon><infon key="name_4">surname:Peng;given-names:X.</infon><infon key="name_5">surname:Wu;given-names:F.X.</infon><infon key="name_6">surname:Pan;given-names:Y.</infon><infon key="pub-id_doi">10.1093/bioinformatics/btw228</infon><infon key="pub-id_pmid">27153662</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">32</infon><infon key="year">2016</infon><offset>32317</offset><text>Drug repositioning based on comprehensive similarity measures and Bi-Random walk algorithm</text></passage><passage><infon key="name_0">surname:Oh;given-names:M.</infon><infon key="name_1">surname:Ahn;given-names:J.</infon><infon key="name_2">surname:Yoon;given-names:Y.</infon><infon key="pub-id_doi">10.1371/journal.pone.0111668</infon><infon key="pub-id_pmid">25356910</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2014</infon><offset>32408</offset><text>A network-based classification model for deriving novel drug-disease associations and assessing their molecular actions</text></passage><passage><infon key="fpage">1445</infon><infon key="lpage">1454</infon><infon key="name_0">surname:Mamoshina;given-names:P.</infon><infon key="name_1">surname:Vieira;given-names:A.</infon><infon key="name_2">surname:Putin;given-names:E.</infon><infon key="name_3">surname:Zhavoronkov;given-names:A.</infon><infon key="pub-id_doi">10.1021/acs.molpharmaceut.5b00982</infon><infon key="pub-id_pmid">27007977</infon><infon key="section_type">REF</infon><infon key="source">Mol. Pharm.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2016</infon><offset>32528</offset><text>Applications of Deep Learning in Biomedicine</text></passage><passage><infon key="fpage">436</infon><infon key="lpage">444</infon><infon key="name_0">surname:Lecun;given-names:Y.</infon><infon key="name_1">surname:Bengio;given-names:Y.</infon><infon key="name_2">surname:Hinton;given-names:G.</infon><infon key="pub-id_doi">10.1038/nature14539</infon><infon key="pub-id_pmid">26017442</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">521</infon><infon key="year">2015</infon><offset>32573</offset><text>Deep learning</text></passage><passage><infon key="fpage">2524</infon><infon key="lpage">2530</infon><infon key="name_0">surname:Aliper;given-names:A.</infon><infon key="name_1">surname:Plis;given-names:S.</infon><infon key="name_2">surname:Artemov;given-names:A.</infon><infon key="name_3">surname:Ulloa;given-names:A.</infon><infon key="name_4">surname:Mamoshina;given-names:P.</infon><infon key="name_5">surname:Zhavoronkov;given-names:A.</infon><infon key="pub-id_doi">10.1021/acs.molpharmaceut.6b00248</infon><infon key="pub-id_pmid">27200455</infon><infon key="section_type">REF</infon><infon key="source">Mol. Pharm.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2016</infon><offset>32587</offset><text>Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data</text></passage><passage><infon key="fpage">10</infon><infon key="name_0">surname:Unterthiner;given-names:T.</infon><infon key="name_1">surname:Mayr;given-names:A.</infon><infon key="name_2">surname:Klambauer;given-names:G.</infon><infon key="name_3">surname:Hochreiter;given-names:S.</infon><infon key="pub-id_doi">10.3389/fenvs.2015.00080</infon><infon key="section_type">REF</infon><infon key="source">Front. Environ. Sci.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2015</infon><offset>32712</offset><text>Toxicity Prediction using Deep Learning</text></passage><passage><infon key="name_0">surname:Ramsundar;given-names:B.</infon><infon key="name_1">surname:Kearnes;given-names:S.</infon><infon key="name_2">surname:Riley;given-names:P.</infon><infon key="name_3">surname:Webster;given-names:D.</infon><infon key="name_4">surname:Konerding;given-names:D.</infon><infon key="name_5">surname:Pande;given-names:V.</infon><infon key="pub-id_arxiv">1502.02072</infon><infon key="section_type">REF</infon><infon key="source">arXiv</infon><infon key="type">ref</infon><infon key="year">2015</infon><offset>32752</offset><text>Massively Multitask Networks for Drug Discovery</text></passage><passage><infon key="fpage">218</infon><infon key="lpage">223</infon><infon key="name_0">surname:Schadt;given-names:E.E.</infon><infon key="pub-id_doi">10.1038/nature08454</infon><infon key="pub-id_pmid">19741703</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">461</infon><infon key="year">2009</infon><offset>32800</offset><text>Molecular networks as sensors and drivers of common human diseases</text></passage><passage><infon key="fpage">631</infon><infon key="lpage">641</infon><infon key="name_0">surname:Azuaje;given-names:F.</infon><infon key="pub-id_doi">10.1093/cvr/cvs289</infon><infon key="pub-id_pmid">22977007</infon><infon key="section_type">REF</infon><infon key="source">Cardiovasc. Res.</infon><infon key="type">ref</infon><infon key="volume">97</infon><infon key="year">2013</infon><offset>32867</offset><text>Drug interaction networks: An introduction to translational and clinical applications</text></passage><passage><infon key="name_0">surname:Ye;given-names:H.</infon><infon key="name_1">surname:Liu;given-names:Q.</infon><infon key="name_2">surname:Wei;given-names:J.</infon><infon key="pub-id_doi">10.1371/journal.pone.0087864</infon><infon key="pub-id_pmid">24505324</infon><infon key="section_type">REF</infon><infon key="source">PLoS ONE</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2014</infon><offset>32953</offset><text>Construction of drug network based on side effects and its application for drug repositioning</text></passage><passage><infon key="name_0">surname:Mizutani;given-names:S.</infon><infon key="name_1">surname:Pauwels;given-names:E.</infon><infon key="name_2">surname:Stoven;given-names:V.</infon><infon key="name_3">surname:Goto;given-names:S.</infon><infon key="name_4">surname:Yamanishi;given-names:Y.</infon><infon key="pub-id_doi">10.1093/bioinformatics/bts383</infon><infon key="pub-id_pmid">22962476</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">28</infon><infon key="year">2012</infon><offset>33047</offset><text>Relating drug-protein interaction network with drug side effects</text></passage><passage><infon key="fpage">263</infon><infon key="lpage">266</infon><infon key="name_0">surname:Campillos;given-names:M.</infon><infon key="name_1">surname:Kuhn;given-names:M.</infon><infon key="name_2">surname:Gavin;given-names:A.-C.</infon><infon key="name_3">surname:Jensen;given-names:L.J.</infon><infon key="name_4">surname:Bork;given-names:P.</infon><infon key="pub-id_doi">10.1126/science.1158140</infon><infon key="pub-id_pmid">18621671</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">321</infon><infon key="year">2008</infon><offset>33112</offset><text>Drug target identification using side-effect similarity</text></passage><passage><infon key="name_0">surname:Brown;given-names:A.S.</infon><infon key="name_1">surname:Kong;given-names:S.W.</infon><infon key="name_2">surname:Kohane;given-names:I.S.</infon><infon key="name_3">surname:Patel;given-names:C.J.</infon><infon key="pub-id_doi">10.1186/s12859-016-0931-y</infon><infon key="pub-id_pmid">26860211</infon><infon key="section_type">REF</infon><infon key="source">BMC Bioinform.</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2016</infon><offset>33168</offset><text>ksRepo: A generalized platform for computational drug repositioning</text></passage><passage><infon key="fpage">W193</infon><infon key="lpage">W199</infon><infon key="name_0">surname:Setoain;given-names:J.</infon><infon key="name_1">surname:Franch;given-names:M.</infon><infon key="name_2">surname:Martínez;given-names:M.</infon><infon key="name_3">surname:Tabas-Madrid;given-names:D.</infon><infon key="name_4">surname:Sorzano;given-names:C.O.S.</infon><infon key="name_5">surname:Bakker;given-names:A.</infon><infon key="name_6">surname:Gonzalez-Couto;given-names:E.</infon><infon key="name_7">surname:Elvira;given-names:J.</infon><infon key="name_8">surname:Pascual-Montano;given-names:A.</infon><infon key="pub-id_doi">10.1093/nar/gkv445</infon><infon key="pub-id_pmid">25940629</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2015</infon><offset>33236</offset><text>NFFinder: An online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning</text></passage><passage><infon key="fpage">1170</infon><infon key="lpage">1182</infon><infon key="name_0">surname:Chang;given-names:R.</infon><infon key="name_1">surname:Shoemaker;given-names:R.</infon><infon key="name_2">surname:Wang;given-names:W.</infon><infon key="pub-id_doi">10.1109/TCBB.2011.18</infon><infon key="pub-id_pmid">21282866</infon><infon key="section_type">REF</infon><infon key="source">IEEE/ACM Trans. Comput. Biol. Bioinform.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2011</infon><offset>33363</offset><text>A novel knowledge-driven systems biology approach for phenotype prediction upon genetic intervention</text></passage><passage><infon key="name_0">surname:Chen;given-names:H.</infon><infon key="name_1">surname:Zhang;given-names:H.</infon><infon key="name_2">surname:Zhang;given-names:Z.</infon><infon key="name_3">surname:Cao;given-names:Y.</infon><infon key="name_4">surname:Tang;given-names:W.</infon><infon key="pub-id_doi">10.1155/2015/130620</infon><infon key="pub-id_pmid">25969690</infon><infon key="section_type">REF</infon><infon key="source">Comput. Math. Methods Med.</infon><infon key="type">ref</infon><infon key="volume">2015</infon><infon key="year">2015</infon><offset>33464</offset><text>Network-based inference methods for drug repositioning</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">9</infon><infon key="name_0">surname:Wu;given-names:C.</infon><infon key="name_1">surname:Gudivada;given-names:R.C.</infon><infon key="name_2">surname:Aronow;given-names:B.J.</infon><infon key="name_3">surname:Jegga;given-names:A.G.</infon><infon key="pub-id_doi">10.1186/1752-0509-7-S5-S6</infon><infon key="pub-id_pmid">23280066</infon><infon key="section_type">REF</infon><infon key="source">BMC Syst. Biol.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2013</infon><offset>33519</offset><text>Computational drug repositioning through heterogeneous network clustering</text></passage><passage><infon key="name_0">surname:Chen;given-names:J.</infon><infon key="name_1">surname:Bardes;given-names:E.E.</infon><infon key="name_2">surname:Aronow;given-names:B.J.</infon><infon key="name_3">surname:Jegga;given-names:A.G.</infon><infon key="pub-id_doi">10.1093/nar/gkp427</infon><infon key="pub-id_pmid">19465376</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">2009</infon><offset>33593</offset><text>ToppGene Suite for gene list enrichment analysis and candidate gene prioritization</text></passage><passage><infon key="name_0">surname:Luo;given-names:Y.</infon><infon key="name_1">surname:Zhao;given-names:X.</infon><infon key="name_2">surname:Zhou;given-names:J.</infon><infon key="name_3">surname:Yang;given-names:J.</infon><infon key="name_4">surname:Zhang;given-names:Y.</infon><infon key="name_5">surname:Kuang;given-names:W.</infon><infon key="name_6">surname:Peng;given-names:J.</infon><infon key="name_7">surname:Chen;given-names:L.</infon><infon key="name_8">surname:Zeng;given-names:J.</infon><infon key="pub-id_doi">10.1038/s41467-017-00680-8</infon><infon key="pub-id_pmid">28924171</infon><infon key="section_type">REF</infon><infon key="source">Nat. Commun.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2017</infon><offset>33676</offset><text>A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">35</infon><infon key="name_0">surname:Himmelstein;given-names:D.S.</infon><infon key="name_1">surname:Lizee;given-names:A.</infon><infon key="name_2">surname:Hessler;given-names:C.</infon><infon key="name_3">surname:Brueggeman;given-names:L.</infon><infon key="name_4">surname:Chen;given-names:S.L.</infon><infon key="name_5">surname:Hadley;given-names:D.</infon><infon key="name_6">surname:Green;given-names:A.</infon><infon key="name_7">surname:Khankhanian;given-names:P.</infon><infon key="name_8">surname:Baranzini;given-names:S.E.</infon><infon key="pub-id_doi">10.7554/eLife.26726</infon><infon key="pub-id_pmid">28936969</infon><infon key="section_type">REF</infon><infon key="source">eLife</infon><infon key="type">ref</infon><infon key="volume">6</infon><infon key="year">2017</infon><offset>33814</offset><text>Systematic integration of biomedical knowledge prioritizes drugs for repurposing</text></passage><passage><infon key="fpage">1075</infon><infon key="lpage">1089</infon><infon key="name_0">surname:Luo;given-names:Y.</infon><infon key="name_1">surname:Thompson;given-names:W.K.</infon><infon key="name_2">surname:Herr;given-names:T.M.</infon><infon key="name_3">surname:Zeng;given-names:Z.</infon><infon key="name_4">surname:Berendsen;given-names:M.A.</infon><infon key="name_5">surname:Jonnalagadda;given-names:S.R.</infon><infon key="name_6">surname:Carson;given-names:M.B.</infon><infon key="name_7">surname:Starren;given-names:J.</infon><infon key="pub-id_doi">10.1007/s40264-017-0558-6</infon><infon key="pub-id_pmid">28643174</infon><infon key="section_type">REF</infon><infon key="source">Drug Saf.</infon><infon key="type">ref</infon><infon key="volume">40</infon><infon key="year">2017</infon><offset>33895</offset><text>Natural Language Processing for EHR-Based Pharmacovigilance: A Structured Review</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">10</infon><infon key="name_0">surname:Xu;given-names:H.</infon><infon key="name_1">surname:Aldrich;given-names:M.C.</infon><infon key="name_2">surname:Chen;given-names:Q.</infon><infon key="name_3">surname:Liu;given-names:H.</infon><infon key="name_4">surname:Peterson;given-names:N.B.</infon><infon key="name_5">surname:Dai;given-names:Q.</infon><infon key="name_6">surname:Levy;given-names:M.</infon><infon key="name_7">surname:Shah;given-names:A.</infon><infon key="name_8">surname:Han;given-names:X.</infon><infon key="name_9">surname:Ruan;given-names:X.</infon><infon key="pub-id_doi">10.1136/amiajnl-2014-002649</infon><infon key="pub-id_pmid">24335250</infon><infon key="section_type">REF</infon><infon key="source">J. Am. Med. Inform. Assoc.</infon><infon key="type">ref</infon><infon key="year">2014</infon><offset>33976</offset><text>Validating drug repurposing signals using electronic health records: A case study of metformin associated with reduced cancer mortality</text></passage><passage><infon key="fpage">174</infon><infon key="lpage">177</infon><infon key="name_0">surname:Brown;given-names:A.S.</infon><infon key="name_1">surname:Patel;given-names:C.J.</infon><infon key="pub-id_doi">10.1093/bib/bbw110</infon><infon key="pub-id_pmid">27881429</infon><infon key="section_type">REF</infon><infon key="source">Brief. Bioinform.</infon><infon key="type">ref</infon><infon key="volume">19</infon><infon key="year">2018</infon><offset>34112</offset><text>A review of validation strategies for computational drug repositioning</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">9</infon><infon key="name_0">surname:Lee;given-names:W.H.</infon><infon key="pub-id_doi">10.1371/journal.pbio.1002164</infon><infon key="pub-id_pmid">26042736</infon><infon key="section_type">REF</infon><infon key="source">PLoS Biol.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2015</infon><offset>34183</offset><text>Open access target validation is a more efficient way to accelerate drug discovery</text></passage><passage><infon key="name_0">surname:Carter;given-names:A.J.</infon><infon key="name_1">surname:Donner;given-names:A.</infon><infon key="name_2">surname:Lee;given-names:W.H.</infon><infon key="name_3">surname:Bountra;given-names:C.</infon><infon key="pub-id_doi">10.1371/journal.pbio.2001387</infon><infon key="pub-id_pmid">28199324</infon><infon key="section_type">REF</infon><infon key="source">PLoS Biol.</infon><infon key="type">ref</infon><infon key="volume">15</infon><infon key="year">2017</infon><offset>34266</offset><text>Establishing a reliable framework for harnessing the creative power of the scientific crowd</text></passage><passage><infon key="fpage">20</infon><infon key="lpage">33</infon><infon key="name_0">surname:Rijnders;given-names:T.W.</infon><infon key="name_1">surname:Tzalis;given-names:D.</infon><infon key="name_2">surname:Jaroch;given-names:S.</infon><infon key="section_type">REF</infon><infon key="source">J. Med. Dev. Sci.</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">2015</infon><offset>34358</offset><text>The European lead factory—An experiment in colla- borative drug discovery</text></passage><passage><infon key="fpage">534</infon><infon key="lpage">536</infon><infon key="name_0">surname:Munos;given-names:B.</infon><infon key="pub-id_doi">10.1038/clpt.2010.26</infon><infon key="pub-id_pmid">20407458</infon><infon key="section_type">REF</infon><infon key="source">Clin. Pharmacol. Ther.</infon><infon key="type">ref</infon><infon key="volume">87</infon><infon key="year">2010</infon><offset>34434</offset><text>Can open-source drug RD repower pharmaceutical innovation?</text></passage><passage><infon key="fpage">108</infon><infon key="lpage">111</infon><infon key="name_0">surname:Lakhani;given-names:K.R.</infon><infon key="name_1">surname:Boudreau;given-names:K.J.</infon><infon key="name_2">surname:Loh;given-names:P.R.</infon><infon key="name_3">surname:Backstrom;given-names:L.</infon><infon key="name_4">surname:Baldwin;given-names:C.</infon><infon key="name_5">surname:Lonstein;given-names:E.</infon><infon key="name_6">surname:Lydon;given-names:M.</infon><infon key="name_7">surname:MacCormack;given-names:A.</infon><infon key="name_8">surname:Arnaout;given-names:R.A.</infon><infon key="name_9">surname:Guinan;given-names:E.C.</infon><infon key="pub-id_doi">10.1038/nbt.2495</infon><infon key="pub-id_pmid">23392504</infon><infon key="section_type">REF</infon><infon key="source">Nat. Biotechnol.</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2013</infon><offset>34493</offset><text>Prize-based contests can provide solutions to computational biology problems</text></passage><passage><infon key="fpage">472</infon><infon key="lpage">478</infon><infon key="name_0">surname:Bentzien;given-names:J.</infon><infon key="name_1">surname:Muegge;given-names:I.</infon><infon key="name_2">surname:Hamner;given-names:B.</infon><infon key="name_3">surname:Thompson;given-names:D.C.</infon><infon key="pub-id_doi">10.1016/j.drudis.2013.01.002</infon><infon key="pub-id_pmid">23337388</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">18</infon><infon key="year">2013</infon><offset>34570</offset><text>Crowd computing: Using competitive dynamics to develop and refine highly predictive models</text></passage><passage><infon key="fpage">314</infon><infon key="lpage">316</infon><infon key="name_0">surname:Patel;given-names:A.C.</infon><infon key="name_1">surname:Coyle;given-names:A.J.</infon><infon key="pub-id_doi">10.1038/clpt.2013.89</infon><infon key="pub-id_pmid">23645247</infon><infon key="section_type">REF</infon><infon key="source">Clin. Pharmacol. Ther.</infon><infon key="type">ref</infon><infon key="volume">94</infon><infon key="year">2013</infon><offset>34661</offset><text>Building a new biomedical ecosystem: Pfizer’s centers for therapeutic innovation</text></passage><passage><infon key="name_0">surname:Wang;given-names:Z.</infon><infon key="name_1">surname:Monteiro;given-names:C.D.</infon><infon key="name_2">surname:Jagodnik;given-names:K.M.</infon><infon key="name_3">surname:Fernandez;given-names:N.F.</infon><infon key="name_4">surname:Gundersen;given-names:G.W.</infon><infon key="name_5">surname:Rouillard;given-names:A.D.</infon><infon key="name_6">surname:Jenkins;given-names:S.L.</infon><infon key="name_7">surname:Feldmann;given-names:A.S.</infon><infon key="name_8">surname:Hu;given-names:K.S.</infon><infon key="name_9">surname:McDermott;given-names:M.G.</infon><infon key="pub-id_doi">10.1038/ncomms12846</infon><infon key="pub-id_pmid">27667448</infon><infon key="section_type">REF</infon><infon key="source">Nat. Commun.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2016</infon><offset>34744</offset><text>Extraction and analysis of signatures from the Gene Expression Omnibus by the crowd</text></passage><passage><infon key="fpage">74</infon><infon key="name_0">surname:Dorsch;given-names:H.</infon><infon key="name_1">surname:Jurock;given-names:A.E.</infon><infon key="name_2">surname:Schoepe;given-names:S.</infon><infon key="name_3">surname:Lessl;given-names:M.</infon><infon key="name_4">surname:Asadullah;given-names:K.</infon><infon key="pub-id_doi">10.1038/nrd3078-c2</infon><infon key="pub-id_pmid">25430867</infon><infon key="section_type">REF</infon><infon key="source">Nat. Rev. Drug Discov.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2014</infon><offset>34828</offset><text>Grants4Targets: An open innovation initiative to foster drug discovery collaborations</text></passage><passage><infon key="name_0">surname:Markoff;given-names:J.</infon><infon key="section_type">REF</infon><infon key="source">New York Times</infon><infon key="type">ref</infon><infon key="year">2012</infon><offset>34914</offset><text>Scientists see advances in deep learning</text></passage><passage><infon key="fpage">294</infon><infon key="lpage">303</infon><infon key="name_0">surname:Alvim-Gaston;given-names:M.</infon><infon key="name_1">surname:Grese;given-names:T.</infon><infon key="name_2">surname:Mahoui;given-names:A.</infon><infon key="name_3">surname:Palkowitz;given-names:A.</infon><infon key="name_4">surname:Pineiro-Nunez;given-names:M.</infon><infon key="name_5">surname:Watson;given-names:I.</infon><infon key="pub-id_doi">10.2174/1568026613666131127125858</infon><infon key="pub-id_pmid">24283973</infon><infon key="section_type">REF</infon><infon key="source">Curr. Top. Med. Chem.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2014</infon><offset>34955</offset><text>Open Innovation Drug Discovery (OIDD): A Potential Path to Novel Therapeutic Chemical Space</text></passage><passage><infon key="name_0">surname:Margolin;given-names:A.A.</infon><infon key="name_1">surname:Bilal;given-names:E.</infon><infon key="name_2">surname:Huang;given-names:E.</infon><infon key="name_3">surname:Norman;given-names:T.C.</infon><infon key="name_4">surname:Ottestad;given-names:L.</infon><infon key="name_5">surname:Mecham;given-names:B.H.</infon><infon key="name_6">surname:Sauerwine;given-names:B.</infon><infon key="name_7">surname:Kellen;given-names:M.R.</infon><infon key="name_8">surname:Mangravite;given-names:L.M.</infon><infon key="name_9">surname:Furia;given-names:M.D.</infon><infon key="pub-id_doi">10.1126/scitranslmed.3006112</infon><infon key="pub-id_pmid">23596205</infon><infon key="section_type">REF</infon><infon key="source">Sci. Transl. Med.</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2013</infon><offset>35047</offset><text>Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer</text></passage><passage><infon key="fpage">576</infon><infon key="lpage">656</infon><infon key="name_0">surname:Aksulu;given-names:A.</infon><infon key="name_1">surname:Wade;given-names:M.</infon><infon key="pub-id_doi">10.17705/1jais.00245</infon><infon key="section_type">REF</infon><infon key="source">J. Assoc. Inf. Syst.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2010</infon><offset>35149</offset><text>A Comprehensive Review and Synthesis of Open Source Research</text></passage><passage><infon key="fpage">287</infon><infon key="lpage">296</infon><infon key="name_0">surname:Stajich;given-names:J.E.</infon><infon key="name_1">surname:Lapp;given-names:H.</infon><infon key="pub-id_doi">10.1093/bib/bbl026</infon><infon key="pub-id_pmid">16899494</infon><infon key="section_type">REF</infon><infon key="source">Brief. Bioinform.</infon><infon key="type">ref</infon><infon key="volume">7</infon><infon key="year">2006</infon><offset>35210</offset><text>Open source tools and toolkits for bioinformatics: Significance, and where are we?</text></passage><passage><infon key="fpage">87</infon><infon key="lpage">90</infon><infon key="name_0">surname:Kluyver;given-names:T.</infon><infon key="name_1">surname:Ragan-kelley;given-names:B.</infon><infon key="name_2">surname:Pérez;given-names:F.</infon><infon key="name_3">surname:Granger;given-names:B.</infon><infon key="name_4">surname:Bussonnier;given-names:M.</infon><infon key="name_5">surname:Frederic;given-names:J.</infon><infon key="name_6">surname:Kelley;given-names:K.</infon><infon key="name_7">surname:Hamrick;given-names:J.</infon><infon key="name_8">surname:Grout;given-names:J.</infon><infon key="name_9">surname:Corlay;given-names:S.</infon><infon key="pub-id_doi">10.3233/978-1-61499-649-1-87</infon><infon key="section_type">REF</infon><infon key="source">Position. Power Acad. Publ. Play. Agents Agendas</infon><infon key="type">ref</infon><infon key="year">2016</infon><offset>35293</offset><text>Jupyter Notebooks—A publishing format for reproducible computational workflows</text></passage><passage><infon key="fpage">2825</infon><infon key="lpage">2830</infon><infon key="name_0">surname:Pedregosa;given-names:F.</infon><infon key="name_1">surname:Varoquaux;given-names:G.</infon><infon key="name_2">surname:Gramfort;given-names:A.</infon><infon key="name_3">surname:Michel;given-names:V.</infon><infon key="name_4">surname:Thirion;given-names:B.</infon><infon key="name_5">surname:Grisel;given-names:O.</infon><infon key="name_6">surname:Blondel;given-names:M.</infon><infon key="name_7">surname:Prettenhofer;given-names:P.</infon><infon key="name_8">surname:Weiss;given-names:R.</infon><infon key="name_9">surname:Dubourg;given-names:V.</infon><infon key="pub-id_doi">10.1007/s13398-014-0173-7.2</infon><infon key="section_type">REF</infon><infon key="source">J. Mach. Learn. Res.</infon><infon key="type">ref</infon><infon key="volume">12</infon><infon key="year">2011</infon><offset>35374</offset><text>Scikit-learn: Machine Learning in Python</text></passage><passage><infon key="fpage">23492353</infon><infon key="name_0">surname:Demšar;given-names:J.</infon><infon key="name_1">surname:Curk;given-names:T.</infon><infon key="name_2">surname:Erjavec;given-names:A.</infon><infon key="name_3">surname:Hočevar;given-names:T.</infon><infon key="name_4">surname:Milutinovič;given-names:M.</infon><infon key="name_5">surname:Možina;given-names:M.</infon><infon key="name_6">surname:Polajnar;given-names:M.</infon><infon key="name_7">surname:Toplak;given-names:M.</infon><infon key="name_8">surname:Starič;given-names:A.</infon><infon key="name_9">surname:Stajdohar;given-names:M.</infon><infon key="section_type">REF</infon><infon key="source">J. Mach. Learn. Res.</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">2013</infon><offset>35415</offset><text>Orange: Data Mining Toolbox in Python</text></passage><passage><infon key="fpage">10</infon><infon key="lpage">18</infon><infon key="name_0">surname:Hall;given-names:M.A.</infon><infon key="name_1">surname:Frank;given-names:E.</infon><infon key="name_2">surname:Holmes;given-names:G.</infon><infon key="name_3">surname:Pfahringer;given-names:B.</infon><infon key="name_4">surname:Reutemann;given-names:P.</infon><infon key="name_5">surname:Witten;given-names:I.H.</infon><infon key="pub-id_doi">10.1145/1656274.1656278</infon><infon key="section_type">REF</infon><infon key="source">SIGKDD Explor.</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">2009</infon><offset>35453</offset><text>The WEKA data mining software: An update</text></passage><passage><infon key="fpage">265</infon><infon key="lpage">284</infon><infon key="name_0">surname:Abadi;given-names:M.</infon><infon key="name_1">surname:Barham;given-names:P.</infon><infon key="name_2">surname:Chen;given-names:J.</infon><infon key="name_3">surname:Chen;given-names:Z.</infon><infon key="name_4">surname:Davis;given-names:A.</infon><infon key="name_5">surname:Dean;given-names:J.</infon><infon key="name_6">surname:Devin;given-names:M.</infon><infon key="name_7">surname:Ghemawat;given-names:S.</infon><infon key="name_8">surname:Irving;given-names:G.</infon><infon key="name_9">surname:Isard;given-names:M.</infon><infon key="section_type">REF</infon><infon key="source">Proceedings of the 12th USENIX Symposium on Operating Systems Design and Implementation (OSDI ’16)</infon><infon key="type">ref</infon><offset>35494</offset><text>TensorFlow: A System for Large-Scale Machine Learning TensorFlow: A system for large-scale machine learning</text></passage><passage><infon key="comment">Available online: https://github.com/fchollet/keras</infon><infon key="name_0">surname:Chollet;given-names:F.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><offset>35602</offset><text>Keras</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">4</infon><infon key="name_0">surname:Paszke;given-names:A.</infon><infon key="name_1">surname:Chanan;given-names:G.</infon><infon key="name_2">surname:Lin;given-names:Z.</infon><infon key="name_3">surname:Gross;given-names:S.</infon><infon key="name_4">surname:Yang;given-names:E.</infon><infon key="name_5">surname:Antiga;given-names:L.</infon><infon key="name_6">surname:Devito;given-names:Z.</infon><infon key="section_type">REF</infon><infon key="source">Adv. Neural Inf. Process. Syst.</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2017</infon><offset>35608</offset><text>Automatic differentiation in PyTorch</text></passage><passage><infon key="name_0">surname:Yu;given-names:D.</infon><infon key="name_1">surname:Huang;given-names:X.</infon><infon key="section_type">REF</infon><infon key="source">Neural Information Processing Systems (NIPS)</infon><infon key="type">ref</infon><infon key="year">2015</infon><offset>35645</offset><text>Microsoft Computational Network Toolkit (CNTK)</text></passage><passage><infon key="name_0">surname:Vedaldi;given-names:A.</infon><infon key="name_1">surname:Lenc;given-names:K.</infon><infon key="pub-id_arxiv">1412.4564</infon><infon key="section_type">REF</infon><infon key="source">arXiv</infon><infon key="type">ref</infon><infon key="year">2014</infon><offset>35692</offset><text>MatConvNet—Convolutional Neural Networks for MATLAB</text></passage><passage><infon key="fpage">361</infon><infon key="lpage">362</infon><infon key="name_0">surname:Bastian;given-names:M.</infon><infon key="name_1">surname:Heymann;given-names:S.</infon><infon key="name_2">surname:Jacomy;given-names:M.</infon><infon key="section_type">REF</infon><infon key="source">Proceedings of the Third International AAAI Conference on Weblogs and Social Media</infon><infon key="type">ref</infon><offset>35746</offset><text>Gephi: An Open Source Software for Exploring and Manipulating Networks</text></passage><passage><infon key="fpage">2498</infon><infon key="lpage">2504</infon><infon key="name_0">surname:Shannon;given-names:P.</infon><infon key="name_1">surname:Markiel;given-names:A.</infon><infon key="name_2">surname:Ozier;given-names:O.</infon><infon key="name_3">surname:Baliga;given-names:N.S.</infon><infon key="name_4">surname:Wang;given-names:J.T.</infon><infon key="name_5">surname:Ramage;given-names:D.</infon><infon key="name_6">surname:Amin;given-names:N.</infon><infon key="name_7">surname:Schwikowski;given-names:B.</infon><infon key="name_8">surname:Ideker;given-names:T.</infon><infon key="pub-id_doi">10.1101/gr.1239303</infon><infon key="pub-id_pmid">14597658</infon><infon key="section_type">REF</infon><infon key="source">Genome Res.</infon><infon key="type">ref</infon><infon key="volume">13</infon><infon key="year">2003</infon><offset>35817</offset><text>Cytoscape: A software Environment for integrated models of biomolecular interaction networks</text></passage><passage><infon key="fpage">405</infon><infon key="lpage">408</infon><infon key="name_0">surname:Corsello;given-names:S.M.</infon><infon key="name_1">surname:Bittker;given-names:J.A.</infon><infon key="name_2">surname:Liu;given-names:Z.</infon><infon key="name_3">surname:Gould;given-names:J.</infon><infon key="name_4">surname:McCarren;given-names:P.</infon><infon key="name_5">surname:Hirschman;given-names:J.E.</infon><infon key="name_6">surname:Johnston;given-names:S.E.</infon><infon key="name_7">surname:Vrcic;given-names:A.</infon><infon key="name_8">surname:Wong;given-names:B.</infon><infon key="name_9">surname:Khan;given-names:M.</infon><infon key="pub-id_doi">10.1038/nm.4306</infon><infon key="pub-id_pmid">28388612</infon><infon key="section_type">REF</infon><infon key="source">Nat. Med.</infon><infon key="type">ref</infon><infon key="volume">23</infon><infon key="year">2017</infon><offset>35910</offset><text>The Drug Repurposing Hub: A next-generation drug library and information resource</text></passage><passage><infon key="name_0">surname:Jia;given-names:Z.</infon><infon key="name_1">surname:Liu;given-names:Y.</infon><infon key="name_2">surname:Guan;given-names:N.</infon><infon key="name_3">surname:Bo;given-names:X.</infon><infon key="name_4">surname:Luo;given-names:Z.</infon><infon key="name_5">surname:Barnes;given-names:M.R.</infon><infon key="pub-id_doi">10.1186/s12864-016-2737-8</infon><infon key="pub-id_pmid">27234029</infon><infon key="section_type">REF</infon><infon key="source">BMC Genomics</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2016</infon><offset>35992</offset><text>Cogena, a novel tool for co-expressed gene-set enrichment analysis, applied to drug repositioning and drug mode of action discovery</text></passage><passage><infon key="fpage">283</infon><infon key="lpage">293</infon><infon key="name_0">surname:Altae-Tran;given-names:H.</infon><infon key="name_1">surname:Ramsundar;given-names:B.</infon><infon key="name_2">surname:Pappu;given-names:A.S.</infon><infon key="name_3">surname:Pande;given-names:V.</infon><infon key="pub-id_doi">10.1021/acscentsci.6b00367</infon><infon key="pub-id_pmid">28470045</infon><infon key="section_type">REF</infon><infon key="source">ACS Cent. Sci.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2017</infon><offset>36124</offset><text>Low Data Drug Discovery with One-Shot Learning</text></passage><passage><infon key="name_0">surname:Zhou;given-names:H.</infon><infon key="name_1">surname:Gao;given-names:M.</infon><infon key="name_2">surname:Skolnick;given-names:J.</infon><infon key="pub-id_doi">10.1038/srep11090</infon><infon key="pub-id_pmid">26057345</infon><infon key="section_type">REF</infon><infon key="source">Sci. Rep.</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2015</infon><offset>36171</offset><text>Comprehensive prediction of drug-protein interactions and side effects for the human proteome</text></passage><passage><infon key="name_0">surname:Douguet;given-names:D.</infon><infon key="pub-id_doi">10.1093/nar/gkq322</infon><infon key="pub-id_pmid">20444867</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2010</infon><offset>36265</offset><text>e-LEA3D: A computational-aided drug design web server</text></passage><passage><infon key="name_0">surname:Miteva;given-names:M.A.</infon><infon key="name_1">surname:Guyon;given-names:F.</infon><infon key="name_2">surname:Tufféry;given-names:P.</infon><infon key="pub-id_doi">10.1093/nar/gkq325</infon><infon key="pub-id_pmid">20444874</infon><infon key="section_type">REF</infon><infon key="source">Nucleic Acids Res.</infon><infon key="type">ref</infon><infon key="volume">38</infon><infon key="year">2010</infon><offset>36319</offset><text>Frog2: Efficient 3D conformation ensemble generator for small compounds</text></passage><passage><infon key="fpage">2523</infon><infon key="lpage">2529</infon><infon key="name_0">surname:Zu;given-names:S.</infon><infon key="name_1">surname:Chen;given-names:T.</infon><infon key="name_2">surname:Li;given-names:S.</infon><infon key="pub-id_doi">10.1093/bioinformatics/btv181</infon><infon key="pub-id_pmid">25819672</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">31</infon><infon key="year">2015</infon><offset>36391</offset><text>Global optimization-based inference of chemogenomic features from drug-target interactions</text></passage><passage><infon key="name_0">surname:Louhimo;given-names:R.</infon><infon key="name_1">surname:Laakso;given-names:M.</infon><infon key="name_2">surname:Belitskin;given-names:D.</infon><infon key="name_3">surname:Klefström;given-names:J.</infon><infon key="name_4">surname:Lehtonen;given-names:R.</infon><infon key="name_5">surname:Hautaniemi;given-names:S.</infon><infon key="pub-id_doi">10.1186/s13040-016-0097-1</infon><infon key="pub-id_pmid">27231484</infon><infon key="section_type">REF</infon><infon key="source">BioData Min.</infon><infon key="type">ref</infon><infon key="volume">9</infon><infon key="year">2016</infon><offset>36482</offset><text>Data integration to prioritize drugs using genomics and curated data</text></passage><passage><infon key="fpage">493</infon><infon key="lpage">500</infon><infon key="name_0">surname:Steinbeck;given-names:C.</infon><infon key="name_1">surname:Han;given-names:Y.</infon><infon key="name_2">surname:Kuhn;given-names:S.</infon><infon key="name_3">surname:Horlacher;given-names:O.</infon><infon key="name_4">surname:Luttmann;given-names:E.</infon><infon key="name_5">surname:Willighagen;given-names:E.</infon><infon key="pub-id_doi">10.1021/ci025584y</infon><infon key="pub-id_pmid">12653513</infon><infon key="section_type">REF</infon><infon key="source">J. Chem. Inf. Comput. Sci.</infon><infon key="type">ref</infon><infon key="volume">43</infon><infon key="year">2003</infon><offset>36551</offset><text>The Chemistry Development Kit (CDK): An open-source Java library for chemo- and bioinformatics</text></passage><passage><infon key="fpage">16015</infon><infon key="name_0">surname:Duan;given-names:Q.</infon><infon key="name_1">surname:Reid;given-names:S.P.</infon><infon key="name_2">surname:Clark;given-names:N.R.</infon><infon key="name_3">surname:Wang;given-names:Z.</infon><infon key="name_4">surname:Fernandez;given-names:N.F.</infon><infon key="name_5">surname:Rouillard;given-names:A.D.</infon><infon key="name_6">surname:Readhead;given-names:B.</infon><infon key="name_7">surname:Tritsch;given-names:S.R.</infon><infon key="name_8">surname:Hodos;given-names:R.</infon><infon key="name_9">surname:Hafner;given-names:M.</infon><infon key="pub-id_doi">10.1038/npjsba.2016.15</infon><infon key="pub-id_pmid">28413689</infon><infon key="section_type">REF</infon><infon key="source">NPJ Syst. Biol. Appl.</infon><infon key="type">ref</infon><infon key="volume">2</infon><infon key="year">2016</infon><offset>36646</offset><text>L1000CDS2: LINCS L1000 characteristic direction signatures search engine</text></passage><passage><infon key="fpage">1787</infon><infon key="lpage">1788</infon><infon key="name_0">surname:Carrella;given-names:D.</infon><infon key="name_1">surname:Napolitano;given-names:F.</infon><infon key="name_2">surname:Rispoli;given-names:R.</infon><infon key="name_3">surname:Miglietta;given-names:M.</infon><infon key="name_4">surname:Carissimo;given-names:A.</infon><infon key="name_5">surname:Cutillo;given-names:L.</infon><infon key="name_6">surname:Sirci;given-names:F.</infon><infon key="name_7">surname:Gregoretti;given-names:F.</infon><infon key="name_8">surname:Di Bernardo;given-names:D.</infon><infon key="pub-id_doi">10.1093/bioinformatics/btu058</infon><infon key="pub-id_pmid">24558125</infon><infon key="section_type">REF</infon><infon key="source">Bioinformatics</infon><infon key="type">ref</infon><infon key="volume">30</infon><infon key="year">2014</infon><offset>36719</offset><text>Mantra 2.0: An online collaborative resource for drug mode of action and repurposing by network analysis</text></passage><passage><infon key="name_0">surname:O’Boyle;given-names:N.M.</infon><infon key="name_1">surname:Banck;given-names:M.</infon><infon key="name_2">surname:James;given-names:C.A.</infon><infon key="name_3">surname:Morley;given-names:C.</infon><infon key="name_4">surname:Vandermeersch;given-names:T.</infon><infon key="name_5">surname:Hutchison;given-names:G.R.</infon><infon key="pub-id_doi">10.1186/1758-2946-3-33</infon><infon key="pub-id_pmid">21982300</infon><infon key="section_type">REF</infon><infon key="source">J. Cheminform.</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2011</infon><offset>36824</offset><text>Open Babel: An Open chemical toolbox</text></passage><passage><infon key="fpage">1188</infon><infon key="lpage">1198</infon><infon key="name_0">surname:Williams;given-names:A.J.</infon><infon key="name_1">surname:Harland;given-names:L.</infon><infon key="name_2">surname:Groth;given-names:P.</infon><infon key="name_3">surname:Pettifer;given-names:S.</infon><infon key="name_4">surname:Chichester;given-names:C.</infon><infon key="name_5">surname:Willighagen;given-names:E.L.</infon><infon key="name_6">surname:Evelo;given-names:C.T.</infon><infon key="name_7">surname:Blomberg;given-names:N.</infon><infon key="name_8">surname:Ecker;given-names:G.</infon><infon key="name_9">surname:Goble;given-names:C.</infon><infon key="pub-id_doi">10.1016/j.drudis.2012.05.016</infon><infon key="pub-id_pmid">22683805</infon><infon key="section_type">REF</infon><infon key="source">Drug Discov. Today</infon><infon key="type">ref</infon><infon key="volume">17</infon><infon key="year">2012</infon><offset>36861</offset><text>Open PHACTS: Semantic interoperability for drug discovery</text></passage><passage><infon key="comment">Available online: http://garfield.library.upenn.edu/essays/V1p033y1962-73.pdf</infon><infon key="name_0">surname:Garfield;given-names:E.</infon><infon key="section_type">REF</infon><infon key="type">ref</infon><infon key="year">1966</infon><offset>36919</offset><text>The Who and Why of ISI. Essays of Information Scientist</text></passage><passage><infon key="fpage">253</infon><infon key="pub-id_doi">10.1038/488253a</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">488</infon><infon key="year">2012</infon><offset>36975</offset><text>Repeat after me</text></passage><passage><infon key="fpage">531</infon><infon key="lpage">533</infon><infon key="name_0">surname:Begley;given-names:C.G.</infon><infon key="name_1">surname:Ellis;given-names:L.M.</infon><infon key="pub-id_doi">10.1038/483531a</infon><infon key="pub-id_pmid">22460880</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="volume">483</infon><infon key="year">2012</infon><offset>36991</offset><text>Drug development: Raise standards for preclinical cancer research</text></passage><passage><infon key="name_0">surname:Baker;given-names:M.</infon><infon key="pub-id_doi">10.1038/nature.2015.17711</infon><infon key="section_type">REF</infon><infon key="source">Nature</infon><infon key="type">ref</infon><infon key="year">2015</infon><offset>37057</offset><text>Irreproducible biology research costs put at $28 billion per year</text></passage><passage><infon key="fpage">1226</infon><infon key="lpage">1227</infon><infon key="name_0">surname:Peng;given-names:R.D.</infon><infon key="pub-id_doi">10.1126/science.1213847</infon><infon key="pub-id_pmid">22144613</infon><infon key="section_type">REF</infon><infon key="source">Science</infon><infon key="type">ref</infon><infon key="volume">334</infon><infon key="year">2011</infon><offset>37123</offset><text>Reproducible research in computational science</text></passage><passage><infon key="name_0">surname:Gentleman;given-names:R.</infon><infon key="pub-id_doi">10.2202/1544-6115.1034</infon><infon key="pub-id_pmid">16646837</infon><infon key="section_type">REF</infon><infon key="source">Stat. Appl. Genet. Mol. Biol.</infon><infon key="type">ref</infon><infon key="volume">4</infon><infon key="year">2005</infon><offset>37170</offset><text>Reproducible Research: A Bioinformatics Case Study</text></passage><passage><infon key="fpage">132</infon><infon key="lpage">143</infon><infon key="name_0">surname:Guney;given-names:E.</infon><infon key="section_type">REF</infon><infon key="source">Pac. Symp. Biocomput.</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">2016</infon><offset>37221</offset><text>Reproducible Drug Repurposing: When Similarity Does Not Suffice</text></passage><passage><infon key="fpage">160018</infon><infon key="name_0">surname:Wilkinson;given-names:M.D.</infon><infon key="name_1">surname:Dumontier;given-names:M.</infon><infon key="name_2">surname:Aalbersberg;given-names:I.J.</infon><infon key="name_3">surname:Appleton;given-names:G.</infon><infon key="name_4">surname:Axton;given-names:M.</infon><infon key="name_5">surname:Baak;given-names:A.</infon><infon key="name_6">surname:Blomberg;given-names:N.</infon><infon key="name_7">surname:Boiten;given-names:J.-W.</infon><infon key="name_8">surname:da Silva Santos;given-names:L.B.</infon><infon key="name_9">surname:Bourne;given-names:P.E.</infon><infon key="pub-id_doi">10.1038/sdata.2016.18</infon><infon key="pub-id_pmid">26978244</infon><infon key="section_type">REF</infon><infon key="source">Sci. Data</infon><infon key="type">ref</infon><infon key="volume">3</infon><infon key="year">2016</infon><offset>37285</offset><text>The FAIR Guiding Principles for scientific data management and stewardship</text></passage><passage><infon key="name_0">surname:Torre;given-names:D.</infon><infon key="name_1">surname:Krawczuk;given-names:P.</infon><infon key="name_2">surname:Jagodnik;given-names:K.M.</infon><infon key="name_3">surname:Lachmann;given-names:A.</infon><infon key="name_4">surname:Wang;given-names:Z.</infon><infon key="name_5">surname:Wang;given-names:L.</infon><infon key="name_6">surname:Kuleshov;given-names:M.V.</infon><infon key="name_7">surname:Ma’Ayan;given-names:A.</infon><infon key="pub-id_doi">10.1038/sdata.2018.23</infon><infon key="pub-id_pmid">29485625</infon><infon key="section_type">REF</infon><infon key="source">Sci. Data</infon><infon key="type">ref</infon><infon key="volume">5</infon><infon key="year">2018</infon><offset>37360</offset><text>Datasets2Tools, repository and search engine for bioinformatics datasets, tools and canned analyses</text></passage><passage><infon key="name_0">surname:Ram;given-names:K.</infon><infon key="pub-id_doi">10.1186/1751-0473-8-7</infon><infon key="pub-id_pmid">23448176</infon><infon key="section_type">REF</infon><infon key="source">Source Code Biol. Med.</infon><infon key="type">ref</infon><infon key="volume">8</infon><infon key="year">2013</infon><offset>37460</offset><text>Git can facilitate greater reproducibility and increased transparency in science</text></passage><passage><infon key="fpage">2</infon><infon key="name_0">surname:Merkel;given-names:D.</infon><infon key="section_type">REF</infon><infon key="source">Linux J.</infon><infon key="type">ref</infon><infon key="volume">2014</infon><infon key="year">2014</infon><offset>37541</offset><text>Docker: Lightweight Linux containers for consistent development and deployment</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t001.xml</infon><infon key="id">pharmaceuticals-11-00057-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>37620</offset><text>Examples of repositioned drugs (adapted in part from, this list is neither extensive nor exhaustive).</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t001.xml</infon><infon key="id">pharmaceuticals-11-00057-t001</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Original Indication&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;New Indication&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Allopurinol&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gout&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Amantadine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Influenza&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Parkinson’s disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Amphotericin&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Antifungal&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leishmaniasis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Arsenic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Syphilis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leukemia&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Aspirin&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inflammation, pain&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Antiplatelet&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Atomexetine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depressive disorder&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ADHD&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bimatoprost&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glaucoma&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Promoting eyelash growth&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bromocriptine &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Parkinson’s disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Diabetes mellitus&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bupropion&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Smoking cessation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colchicine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gout&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Recurrent pericarditis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colesevelam&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hyperlipidemia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type 2 diabetes mellitus&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dapsone&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leprosy&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Malaria&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disulfiram&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alcoholism&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Melanoma&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Doxepin&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depressive disorder&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Antipruritic&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Eflornithine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ADHD&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Finasteride&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Benign prostatic hyperplasia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Male pattern baldness&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gabapentin&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Epilepsy&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neuropathic pain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gemcitabine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Antiviral&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lomitapide&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lipidemia&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Familial hypercholesterolemia&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Methotrexate&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Psoriasis, rheumatoid arthritis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Miltefosine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Visceral leishmaniasis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Minoxidil&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hypertension&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hair loss&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Naltrexone&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Opioid addiction&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alcohol withdrawal&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Naproxen&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inflammation, pain&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alzheimer’s disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nortriptyline&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Depression&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neuropathic pain&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Premetrexed&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Mesothelioma&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lung cancer&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Propranolol&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hypertension&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Migraine prophylaxis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Raloxifene&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Contraceptive&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Osteoporosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sildenafil&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Angina&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Erectile dysfunction; pulmonary hypertension&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Thalidomide&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Morning sickness&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leprosy; multiple myeloma&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tretinoin&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Acne&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Leukemia&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Zidovudine&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;HIV/AIDS&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Zileuton&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Asthma&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Acne&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>37722</offset><text>Drug	Original Indication	New Indication	 	Allopurinol	Cancer	Gout	 	Amantadine	Influenza	Parkinson’s disease	 	Amphotericin	Antifungal	Leishmaniasis	 	Arsenic	Syphilis	Leukemia	 	Aspirin	Inflammation, pain	Antiplatelet	 	Atomexetine	Depressive disorder	ADHD	 	Bimatoprost	Glaucoma	Promoting eyelash growth	 	Bromocriptine 	Parkinson’s disease	Diabetes mellitus	 	Bupropion	Depression	Smoking cessation	 	Colchicine	Gout	Recurrent pericarditis	 	Colesevelam	Hyperlipidemia	Type 2 diabetes mellitus	 	Dapsone	Leprosy	Malaria	 	Disulfiram	Alcoholism	Melanoma	 	Doxepin	Depressive disorder	Antipruritic	 	Eflornithine	Depression	ADHD	 	Finasteride	Benign prostatic hyperplasia	Male pattern baldness	 	Gabapentin	Epilepsy	Neuropathic pain	 	Gemcitabine	Antiviral	Cancer	 	Lomitapide	Lipidemia	Familial hypercholesterolemia	 	Methotrexate	Cancer	Psoriasis, rheumatoid arthritis	 	Miltefosine	Cancer	Visceral leishmaniasis	 	Minoxidil	Hypertension	Hair loss	 	Naltrexone	Opioid addiction	Alcohol withdrawal	 	Naproxen	Inflammation, pain	Alzheimer’s disease	 	Nortriptyline	Depression	Neuropathic pain	 	Premetrexed	Mesothelioma	Lung cancer	 	Propranolol	Hypertension	Migraine prophylaxis	 	Raloxifene	Contraceptive	Osteoporosis	 	Sildenafil	Angina	Erectile dysfunction; pulmonary hypertension	 	Thalidomide	Morning sickness	Leprosy; multiple myeloma	 	Tretinoin	Acne	Leukemia	 	Zidovudine	Cancer	HIV/AIDS	 	Zileuton	Asthma	Acne	 	</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t002.xml</infon><infon key="id">pharmaceuticals-11-00057-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>39152</offset><text>Drug and Disease Centric Database Resources.</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t002.xml</infon><infon key="id">pharmaceuticals-11-00057-t002</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Description&lt;/th&gt;&lt;th align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;URL&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ref.&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ADReCS&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;System Toxicology and in silico drug safety evaluation. Contains 137,619 Drug-ADR pairs&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://bioinf.xmu.edu.cn/ADReCS/&quot;&gt;http://bioinf.xmu.edu.cn/ADReCS/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B41-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;41&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ChEMBL&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database of bioactive drug-like small molecules and abstracted bioactivities&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.ebi.ac.uk/chembl&quot;&gt;https://www.ebi.ac.uk/chembl&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B42-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;42&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ChemSpider&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database of 64 million chemical structures&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.chemspider.com/&quot;&gt;http://www.chemspider.com/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B43-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;43&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clue (L1000 Platform) &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dataset of transcriptional responses of human cells to chemical and genetic perturbation. 1.2 Million L1000 profiles and tools for their analysis.&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://clue.io/&quot;&gt;https://clue.io/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B44-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Comparative Toxicogenomics Database &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Associations of Drug-Gene, Gene-Disease, Drug-Disease and gene-gene&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://ctdbase.org/&quot;&gt;http://ctdbase.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B45-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;45&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DailyMED&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Catalogue of drug listings/drug label information &lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://dailymed.nlm.nih.gov/dailymed/&quot;&gt;https://dailymed.nlm.nih.gov/dailymed/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B46-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;46&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DGIdb&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug-gene annotations, interactions and potential drug ability database&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://dgidb.org/&quot;&gt;http://dgidb.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B47-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;47&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DrugBank&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Contains 11,000 drug entries and each entry contains more than 200 data fields of chemical information and drug targets.&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.drugbank.ca/&quot;&gt;https://www.drugbank.ca/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B48-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;48&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DrugCentral&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Information on active ingredients chemical entities, pharmaceutical products, drug mode of action, indications, pharmacologic action&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://drugcentral.org/&quot;&gt;http://drugcentral.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B49-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;49&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;e-Drug3D &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;e-Drug3D offers a facility to explore FDA approved drugs and active metabolites&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://chemoinfo.ipmc.cnrs.fr/MOLDB/index.html&quot;&gt;http://chemoinfo.ipmc.cnrs.fr/MOLDB/index.html&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B50-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;50&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genomics of Drug Sensitivity in Cancer (GDSC) &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Screenings of &amp;gt;1000 genetically characterized human cancer cell lines with a wide range of anti-cancer therapeutics&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.cancerrxgene.org/&quot;&gt;http://www.cancerrxgene.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B51-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;51&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inxight Drugs&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A comprehensive portal for drug development information from NCATS&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://drugs.ncats.io/ginas/app&quot;&gt;https://drugs.ncats.io/ginas/app&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open Targets Platform&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;comprehensive and robust data integration for access to and visualization of potential drug targets associated with disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.targetvalidation.org&quot;&gt;https://www.targetvalidation.org&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B52-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;52&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PharmGKB &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Curated dataset of genetic variation on drug response&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.pharmgkb.org/&quot;&gt;https://www.pharmgkb.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B53-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;53&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;pkCSM&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Small-molecule pharmacokinetic (ADMET) properties prediction using SMILE data&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://biosig.unimelb.edu.au/pkcsm/prediction&quot;&gt;http://biosig.unimelb.edu.au/pkcsm/prediction&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B54-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;54&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Project Achilles &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A genome-wide catalog of tumor dependencies, to identify vulnerabilities associated with genetic and epigenetic alterations&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://portals.broadinstitute.org/achilles&quot;&gt;https://portals.broadinstitute.org/achilles&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B55-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;55&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Promiscuous &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database contains three different types of entities: drugs, proteins and side-effects as well as relations between them&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://bioinformatics.charite.de/promiscuous/&quot;&gt;http://bioinformatics.charite.de/promiscuous/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B56-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;56&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PubChem&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PubChem contains more than 90 million compounds chemical information along with their bio activities, gene and protein targets&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://pubchem.ncbi.nlm.nih.gov/&quot;&gt;http://pubchem.ncbi.nlm.nih.gov/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B57-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;57&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SIDER&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Information on marketed medicines and their recorded adverse drug reactions&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://sideeffects.embl.de/&quot;&gt;http://sideeffects.embl.de/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B58-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;58&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STITCH&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;68,000 chemicals, interactions and over 1.5 million proteins in 373 species&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://stitch.embl.de/&quot;&gt;http://stitch.embl.de/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B59-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;59&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;SuperPred &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A prediction webserver for ATC code and target prediction of compounds&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://prediction.charite.de/&quot;&gt;http://prediction.charite.de/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B60-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;60&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Therapeutic Target Database (TTD) &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dataset of known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these target&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://bidd.nus.edu.sg/group/cjttd/&quot;&gt;http://bidd.nus.edu.sg/group/cjttd/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B61-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;61&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Toxin and Toxin-Target Database (T3DB)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A database of 3673 toxins described by 41,733 synonyms, including pollutants, pesticides, drugs, and food toxins, which are linked to 2087 corresponding toxin target records&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.t3db.ca/&quot;&gt;http://www.t3db.ca/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B62-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;62&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Human Protein Atlas&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease and Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Consists of three separate parts; the Tissue Atlas showing the distribution of the proteins across all major tissues and organs in the human body, the Cell Atlas showing the subcellular localization of proteins in single cells, and finally the Pathology Atlas showing the impact of protein levels for survival of patients with cancer.&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.proteinatlas.org/&quot;&gt;https://www.proteinatlas.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B63-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;63&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;KEGG Medicus&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease and Drug&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Collection of databases dealing with genomes, biological pathways, diseases, drugs, and chemical substances&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.genome.jp/kegg/disease/&quot;&gt;http://www.genome.jp/kegg/disease/&lt;/uri&gt;
&lt;break/&gt;
&lt;uri xlink:href=&quot;http://www.kegg.jp/&quot;&gt;http://www.kegg.jp/&lt;/uri&gt;
&lt;break/&gt;
&lt;uri xlink:href=&quot;http://www.genome.jp/kegg/drug/&quot;&gt;http://www.genome.jp/kegg/drug/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B64-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;64&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;PsychEncode&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.synapse.org//#!Synapse:syn4921369/wiki/235539&quot;&gt;https://www.synapse.org//#!Synapse:syn4921369/wiki/235539&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B65-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;65&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Allen Brain Atlas&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Gene expression maps for mouse and human brain&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.brain-map.org/&quot;&gt;http://www.brain-map.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B66-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;66&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ArrayExpress&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Micro array gene expression data at EBI&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.ebi.ac.uk/arrayexpress&quot;&gt;https://www.ebi.ac.uk/arrayexpress&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B67-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;67&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CCLE&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database of mRNA expression and mutation data over 1100 cancer cell lines&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://portals.broadinstitute.org/ccle&quot;&gt;https://portals.broadinstitute.org/ccle&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B68-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;68&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COSMIC &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Catalogue of somatic mutations in human cancer&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://cancer.sanger.ac.uk/cosmic&quot;&gt;http://cancer.sanger.ac.uk/cosmic&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B69-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;69&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;dbGAP&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Catalogue of somatic mutations causing cancer&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.ncbi.nlm.nih.gov/gap&quot;&gt;http://www.ncbi.nlm.nih.gov/gap&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B70-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;70&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;dbSNP&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database of single nucleotide polymorphisms&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.ncbi.nlm.nih.gov/snp&quot;&gt;https://www.ncbi.nlm.nih.gov/snp&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B71-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;71&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;dbVar&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Public archives for genomic structural variation&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.ncbi.nlm.nih.gov/dbvar&quot;&gt;https://www.ncbi.nlm.nih.gov/dbvar&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B72-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;72&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DisGeNET &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database on human disease-associated genes and variants&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.disgenet.org/&quot;&gt;http://www.disgenet.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B73-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;73&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ENCODE &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Database of comprehensive parts list of functional elements in human genome&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://genome.ucsc.edu/ENCODE/&quot;&gt;https://genome.ucsc.edu/ENCODE/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B20-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;20&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Genomics Data Commons&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Harmonized Cancer Datasets with 40 cancer mutated gene projects, 22,147 Genes and 3 million mutations&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://gdc.cancer.gov/&quot;&gt;https://gdc.cancer.gov/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B74-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;74&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GEO&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;High throughput gene expression datasets&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.ncbi.nlm.nih.gov/geo&quot;&gt;http://www.ncbi.nlm.nih.gov/geo&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B75-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;75&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GTex &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Catalog of genetic variations and their influence on gene expressions&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.gtexportal.org/home/&quot;&gt;https://www.gtexportal.org/home/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B76-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;76&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Human Proteome Map &lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Interactive resource with massive peptide sequencing results&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.humanproteomemap.org/&quot;&gt;http://www.humanproteomemap.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B77-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;77&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ICGC&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Dataset with more than 17,000 cancer donors spanning 76 projects and 21 tumor sites&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://icgc.org/&quot;&gt;http://icgc.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B78-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;78&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;IGSR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;1000 genome project data usability and extension&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.internationalgenome.org/&quot;&gt;http://www.internationalgenome.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B79-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;79&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Orphadata&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Rare diseases, drugs and associated genes&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.orphadata.org/cgi-bin/index.php/&quot;&gt;http://www.orphadata.org/cgi-bin/index.php/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B80-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;80&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Roadmap Epigenomics&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Epigenomic maps for stem cells and primary ex vivo tissues selected to represent the normal counterparts of tissues and organ systems frequently involved in human disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.roadmapepigenomics.org/&quot;&gt;http://www.roadmapepigenomics.org/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B81-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;81&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;STRING&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Disease&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Protein-Protein interaction, analysis, and networks&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://string-db.org/cgi/input.pl&quot;&gt;https://string-db.org/cgi/input.pl&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B82-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;82&lt;/xref&gt; &lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>39197</offset><text>Database	Type	Description	URL	Ref.	 	ADReCS	Drug	System Toxicology and in silico drug safety evaluation. Contains 137,619 Drug-ADR pairs			 	ChEMBL	Drug	Database of bioactive drug-like small molecules and abstracted bioactivities			 	ChemSpider	Drug	Database of 64 million chemical structures			 	Clue (L1000 Platform) 	Drug	Dataset of transcriptional responses of human cells to chemical and genetic perturbation. 1.2 Million L1000 profiles and tools for their analysis.			 	Comparative Toxicogenomics Database 	Drug	Associations of Drug-Gene, Gene-Disease, Drug-Disease and gene-gene			 	DailyMED	Drug	Catalogue of drug listings/drug label information 			 	DGIdb	Drug	Drug-gene annotations, interactions and potential drug ability database			 	DrugBank	Drug	Contains 11,000 drug entries and each entry contains more than 200 data fields of chemical information and drug targets.			 	DrugCentral	Drug	Information on active ingredients chemical entities, pharmaceutical products, drug mode of action, indications, pharmacologic action			 	e-Drug3D 	Drug	e-Drug3D offers a facility to explore FDA approved drugs and active metabolites			 	Genomics of Drug Sensitivity in Cancer (GDSC) 	Drug	Screenings of &gt;1000 genetically characterized human cancer cell lines with a wide range of anti-cancer therapeutics			 	Inxight Drugs	Drug	A comprehensive portal for drug development information from NCATS			 	Open Targets Platform	Drug	comprehensive and robust data integration for access to and visualization of potential drug targets associated with disease			 	PharmGKB 	Drug	Curated dataset of genetic variation on drug response			 	pkCSM	Drug	Small-molecule pharmacokinetic (ADMET) properties prediction using SMILE data			 	Project Achilles 	Drug	A genome-wide catalog of tumor dependencies, to identify vulnerabilities associated with genetic and epigenetic alterations			 	Promiscuous 	Drug	Database contains three different types of entities: drugs, proteins and side-effects as well as relations between them			 	PubChem	Drug	PubChem contains more than 90 million compounds chemical information along with their bio activities, gene and protein targets			 	SIDER	Drug	Information on marketed medicines and their recorded adverse drug reactions			 	STITCH	Drug	68,000 chemicals, interactions and over 1.5 million proteins in 373 species			 	SuperPred 	Drug	A prediction webserver for ATC code and target prediction of compounds			 	Therapeutic Target Database (TTD) 	Drug	Dataset of known and explored therapeutic protein and nucleic acid targets, the targeted disease, pathway information and the corresponding drugs directed at each of these target			 	Toxin and Toxin-Target Database (T3DB)	Drug	A database of 3673 toxins described by 41,733 synonyms, including pollutants, pesticides, drugs, and food toxins, which are linked to 2087 corresponding toxin target records			 	Human Protein Atlas	Disease and Drug	Consists of three separate parts; the Tissue Atlas showing the distribution of the proteins across all major tissues and organs in the human body, the Cell Atlas showing the subcellular localization of proteins in single cells, and finally the Pathology Atlas showing the impact of protein levels for survival of patients with cancer.			 	KEGG Medicus	Disease and Drug	Collection of databases dealing with genomes, biological pathways, diseases, drugs, and chemical substances			 	PsychEncode	Disease				 	Allen Brain Atlas	Disease	Gene expression maps for mouse and human brain			 	ArrayExpress	Disease	Micro array gene expression data at EBI			 	CCLE	Disease	Database of mRNA expression and mutation data over 1100 cancer cell lines			 	COSMIC 	Disease	Catalogue of somatic mutations in human cancer			 	dbGAP	Disease	Catalogue of somatic mutations causing cancer			 	dbSNP	Disease	Database of single nucleotide polymorphisms			 	dbVar	Disease	Public archives for genomic structural variation			 	DisGeNET 	Disease	Database on human disease-associated genes and variants			 	ENCODE 	Disease	Database of comprehensive parts list of functional elements in human genome			 	Genomics Data Commons	Disease	Harmonized Cancer Datasets with 40 cancer mutated gene projects, 22,147 Genes and 3 million mutations			 	GEO	Disease	High throughput gene expression datasets			 	GTex 	Disease	Catalog of genetic variations and their influence on gene expressions			 	Human Proteome Map 	Disease	Interactive resource with massive peptide sequencing results			 	ICGC	Disease	Dataset with more than 17,000 cancer donors spanning 76 projects and 21 tumor sites			 	IGSR	Disease	1000 genome project data usability and extension			 	Orphadata	Disease	Rare diseases, drugs and associated genes			 	Roadmap Epigenomics	Disease	Epigenomic maps for stem cells and primary ex vivo tissues selected to represent the normal counterparts of tissues and organ systems frequently involved in human disease			 	STRING	Disease	Protein-Protein interaction, analysis, and networks			 	</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t003.xml</infon><infon key="id">pharmaceuticals-11-00057-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>44164</offset><text>Open innovation research resources.</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t003.xml</infon><infon key="id">pharmaceuticals-11-00057-t003</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Name&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Description&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;URL&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Centers for Therapeutic Innovation (CTI)&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Collaborative research platform for clinical applications and drug discovery &lt;xref rid=&quot;B118-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;118&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.pfizercti.com&quot;&gt;https://www.pfizercti.com&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CREEDS&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Crowd-extracted expression of differential signatures &lt;xref rid=&quot;B119-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;119&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://amp.pharm.mssm.edu/CREEDS&quot;&gt;http://amp.pharm.mssm.edu/CREEDS&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Grants4Leads&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Financial support for exploration of new approaches in infectious diseases &lt;xref rid=&quot;B120-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;120&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://www.grants4leads.com/&quot;&gt;https://www.grants4leads.com/&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Kaggle&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Data scientists and statisticians competition platform with few bioinformatics challenges &lt;xref rid=&quot;B117-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;117&lt;/xref&gt;&lt;xref rid=&quot;B121-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;121&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.kaggle.com/&quot;&gt;http://www.kaggle.com/&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open Innovation Drug Discovery&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Academic and Industry researchers open collaboration platform for drug discovery &lt;xref rid=&quot;B122-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;122&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://openinnovation.lilly.com/dd/&quot;&gt;https://openinnovation.lilly.com/dd/&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Sage Bionetworks&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bioinformatics and data science challenge platform building prognostic models for breast cancer &lt;xref rid=&quot;B123-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;123&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://sagebionetworks.org/&quot;&gt;http://sagebionetworks.org/&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;TopCoder&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Machine learning engineers, programmers and data scientists challenge platform &lt;xref rid=&quot;B116-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;116&lt;/xref&gt;&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.topcoder.com&quot;&gt;http://www.topcoder.com&lt;/uri&gt;
&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>44200</offset><text>Name	Description	URL	 	Centers for Therapeutic Innovation (CTI)	Collaborative research platform for clinical applications and drug discovery 		 	CREEDS	Crowd-extracted expression of differential signatures 		 	Grants4Leads	Financial support for exploration of new approaches in infectious diseases 		 	Kaggle	Data scientists and statisticians competition platform with few bioinformatics challenges 		 	Open Innovation Drug Discovery	Academic and Industry researchers open collaboration platform for drug discovery 		 	Sage Bionetworks	Bioinformatics and data science challenge platform building prognostic models for breast cancer 		 	TopCoder	Machine learning engineers, programmers and data scientists challenge platform 		 	</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t004.xml</infon><infon key="id">pharmaceuticals-11-00057-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>44929</offset><text>NIH-NCATS funded new therapeutic uses projects (2013–2018).</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t004.xml</infon><infon key="id">pharmaceuticals-11-00057-t004</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Project/Study Title&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Year&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NCATS Program&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Condition&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307)&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Schizophrenia&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Fyn Inhibition by AZD0530 for Alzheimer’s Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alzheimer’s disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Medication Development of a Novel Therapeutic for Smoking Cessation&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Cigarette smoking&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;A Novel Compound for Alcoholism Treatment: A Translational Strategy&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alcoholism&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Partnering to Treat an Orphan Disease: Duchenne Muscular Dystrophy&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Duchenne muscular dystrophy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Reuse of ZD4054 for Patients with Symptomatic Peripheral Artery Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Peripheral artery disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Therapeutic Strategy for Lymphangioleiomyomatosis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Lymphangioleiomyomatosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Therapeutic Strategy to Slow Progression of Calcific Aortic Valve Stenosis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Calcific aortic valve stenosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Translational Neuroscience Optimization of GlyT1 Inhibitor&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2013&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Schizophrenia&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anti-inflammatory Small Drug as Adjunctive Therapy to Improve Glucometabolic Variables in Obese, Insulin-Resistant Type 2 Diabetic Patients&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Insulin-resistant type 2 diabetes&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Evaluation of AZD9291 in Glioblastoma Patients with Activated EGFR&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Glioblastoma&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Evaluation of a Cathepsin S Inhibitor as a Potential Drug for Chagas Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chagas disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Wee1 and HDAC Inhibition in Relapsed/Refractory AML&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2015&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Relapsed/refractory AML&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Anti-Virulence Drug Repurposing Using Structural Systems Pharmacology&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bacterial virulence&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;CXCR2 Antagonism in the Immunometabolic Regulation of Type 2 Diabetes&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type 2 diabetes&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug Repositioning in Diabetic Nephropathy&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Diabetic nephropathy&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ketorolac and Related NSAIDs for Targeting Rho-Family GTPases in Ovarian Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ovarian cancer&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Network-Driven Drug Repurposing Approaches to Treat Coronary Artery Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Coronary artery disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pre-Clinical Evaluation of a Neutrophil Elastase Inhibitor for the Treatment of Inflammatory Bowel Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Inflammatory bowel disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Quantum Model Repurposing of Cethromycin for Liver Stage Malaria&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Liver-stage malaria&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repurposing Lesogaberan for the Treatment of Type 1 Diabetes&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Type 1 diabetes&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repurposing Misoprostol for Clostridium Difficile Colitis as Identified by PheWAS&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clostridium difficile colitis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repurposing Pyronaridine as a Treatment for the Ebola Virus&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ebola virus&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Therapeutic Repurposing of Benserazide for Colon Cancer&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2016&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Colon cancer&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Computational Repurposing of Chemotherapies for Pulmonary Hypertension&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pulmonary hypertension&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pre-Clinical Evaluation of Vorinostat in Alopecia Areata&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alopecia areata&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pre-Clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Nonalcoholic steatohepatitis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repurposing Pyronaridine as a Treatment for Chagas Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chagas disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Single-Cell-Driven Drug Repositioning Approaches to Target Inflammation in Atherosclerosis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Atherosclerosis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Impact of SAR152954 on Prenatal Alcohol Exposure-Induced Neurobehavioral Deficits&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Neurobehavioral deficits&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;An Endoplasmic Reticulum Calcium Stabilizer for the Treatment of Wolfram Syndrome&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Wolfram syndrome&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hepatocellular carcinoma&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Targeting Glucose Metabolism for the Treatment of Hepatocellular Carcinoma&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Hepatocellular carcinoma&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Application of a Repurposed FDA Approved Drug as a Local Osteogenic Agent&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2017&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;To induce local osteogenesis&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Repurposing Misoprostol to Prevent Recurrence of Clostridium Difficile Infection&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Bench-to-Clinic&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Recurrent Clostridium difficile&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AZD9668: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency, a Genetically Linked Orphan Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Alpha-1 antitrypsin deficiency&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Graft-versus-host disease&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;2018&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NIH-Industry Partnership&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Pulmonary fibrosis&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>44991</offset><text>Project/Study Title	Year	NCATS Program	Condition	 	The Efficacy and Safety of a Selective Estrogen Receptor Beta Agonist (LY500307)	2013	NIH-Industry Partnership	Schizophrenia	 	Fyn Inhibition by AZD0530 for Alzheimer’s Disease	2013	NIH-Industry Partnership	Alzheimer’s disease	 	Medication Development of a Novel Therapeutic for Smoking Cessation	2013	NIH-Industry Partnership	Cigarette smoking	 	A Novel Compound for Alcoholism Treatment: A Translational Strategy	2013	NIH-Industry Partnership	Alcoholism	 	Partnering to Treat an Orphan Disease: Duchenne Muscular Dystrophy	2013	NIH-Industry Partnership	Duchenne muscular dystrophy	 	Reuse of ZD4054 for Patients with Symptomatic Peripheral Artery Disease	2013	NIH-Industry Partnership	Peripheral artery disease	 	Therapeutic Strategy for Lymphangioleiomyomatosis	2013	NIH-Industry Partnership	Lymphangioleiomyomatosis	 	Therapeutic Strategy to Slow Progression of Calcific Aortic Valve Stenosis	2013	NIH-Industry Partnership	Calcific aortic valve stenosis	 	Translational Neuroscience Optimization of GlyT1 Inhibitor	2013	NIH-Industry Partnership	Schizophrenia	 	Anti-inflammatory Small Drug as Adjunctive Therapy to Improve Glucometabolic Variables in Obese, Insulin-Resistant Type 2 Diabetic Patients	2015	NIH-Industry Partnership	Insulin-resistant type 2 diabetes	 	Evaluation of AZD9291 in Glioblastoma Patients with Activated EGFR	2015	NIH-Industry Partnership	Glioblastoma	 	Evaluation of a Cathepsin S Inhibitor as a Potential Drug for Chagas Disease	2015	NIH-Industry Partnership	Chagas disease	 	Wee1 and HDAC Inhibition in Relapsed/Refractory AML	2015	NIH-Industry Partnership	Relapsed/refractory AML	 	Anti-Virulence Drug Repurposing Using Structural Systems Pharmacology	2016	Bench-to-Clinic	Bacterial virulence	 	CXCR2 Antagonism in the Immunometabolic Regulation of Type 2 Diabetes	2016	Bench-to-Clinic	Type 2 diabetes	 	Drug Repositioning in Diabetic Nephropathy	2016	Bench-to-Clinic	Diabetic nephropathy	 	Ketorolac and Related NSAIDs for Targeting Rho-Family GTPases in Ovarian Cancer	2016	Bench-to-Clinic	Ovarian cancer	 	Network-Driven Drug Repurposing Approaches to Treat Coronary Artery Disease	2016	Bench-to-Clinic	Coronary artery disease	 	Pre-Clinical Evaluation of a Neutrophil Elastase Inhibitor for the Treatment of Inflammatory Bowel Disease	2016	Bench-to-Clinic	Inflammatory bowel disease	 	Quantum Model Repurposing of Cethromycin for Liver Stage Malaria	2016	Bench-to-Clinic	Liver-stage malaria	 	Repurposing Lesogaberan for the Treatment of Type 1 Diabetes	2016	Bench-to-Clinic	Type 1 diabetes	 	Repurposing Misoprostol for Clostridium Difficile Colitis as Identified by PheWAS	2016	Bench-to-Clinic	Clostridium difficile colitis	 	Repurposing Pyronaridine as a Treatment for the Ebola Virus	2016	Bench-to-Clinic	Ebola virus	 	Therapeutic Repurposing of Benserazide for Colon Cancer	2016	Bench-to-Clinic	Colon cancer	 	Computational Repurposing of Chemotherapies for Pulmonary Hypertension	2017	Bench-to-Clinic	Pulmonary hypertension	 	Pre-Clinical Evaluation of Vorinostat in Alopecia Areata	2017	Bench-to-Clinic	Alopecia areata	 	Pre-Clinical Testing of a Novel Therapeutic for Nonalcoholic Steatohepatitis	2017	Bench-to-Clinic	Nonalcoholic steatohepatitis	 	Repurposing Pyronaridine as a Treatment for Chagas Disease	2017	Bench-to-Clinic	Chagas disease	 	Single-Cell-Driven Drug Repositioning Approaches to Target Inflammation in Atherosclerosis	2017	Bench-to-Clinic	Atherosclerosis	 	Impact of SAR152954 on Prenatal Alcohol Exposure-Induced Neurobehavioral Deficits	2017	Bench-to-Clinic	Neurobehavioral deficits	 	An Endoplasmic Reticulum Calcium Stabilizer for the Treatment of Wolfram Syndrome	2017	Bench-to-Clinic	Wolfram syndrome	 	Utilization of Phenotypic Precision Medicine to Identify Optimal Drug Combinations for the Treatment of Hepatocellular Carcinoma	2017	Bench-to-Clinic	Hepatocellular carcinoma	 	Targeting Glucose Metabolism for the Treatment of Hepatocellular Carcinoma	2017	Bench-to-Clinic	Hepatocellular carcinoma	 	Application of a Repurposed FDA Approved Drug as a Local Osteogenic Agent	2017	Bench-to-Clinic	To induce local osteogenesis	 	Repurposing Misoprostol to Prevent Recurrence of Clostridium Difficile Infection	2018	Bench-to-Clinic	Recurrent Clostridium difficile	 	AZD9668: A First in Class Disease Modifying Therapy to Treat Alpha-1 Antitrypsin Deficiency, a Genetically Linked Orphan Disease	2018	NIH-Industry Partnership	Alpha-1 antitrypsin deficiency	 	AZD9668 and Neutrophil Elastase Inhibition to Prevent Graft-versus-Host Disease	2018	NIH-Industry Partnership	Graft-versus-host disease	 	Use of the Src Family Kinase Inhibitor Saracatinib in the Treatment of Pulmonary Fibrosis	2018	NIH-Industry Partnership	Pulmonary fibrosis	 	</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t005.xml</infon><infon key="id">pharmaceuticals-11-00057-t005</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>49753</offset><text>Web-tools and open source kits.</text></passage><passage><infon key="file">pharmaceuticals-11-00057-t005.xml</infon><infon key="id">pharmaceuticals-11-00057-t005</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version=&quot;1.0&quot; encoding=&quot;UTF-8&quot;?&gt;
&lt;table xmlns:xlink=&quot;http://www.w3.org/1999/xlink&quot; frame=&quot;hsides&quot; rules=&quot;groups&quot;&gt;&lt;thead&gt;&lt;tr&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tool&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Description&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;URL&lt;/th&gt;&lt;th align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-top:solid thin;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Ref&lt;/th&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clue&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tools for perturbagens (small molecules or genes) query, L1000 cohorts, and gene expression heatmap visualization&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://clue.io&quot;&gt;https://clue.io&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B44-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;44&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Clue Repurposing Tool&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Interactive application to access approved and pre-clinical drug annotations&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://clue.io/repurposing&quot;&gt;https://clue.io/repurposing&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B137-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;137&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;COGENA&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Analysis, visualizing and clustering tool for gene expression profiles&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://github.com/zhilongjia/cogena&quot;&gt;https://github.com/zhilongjia/cogena&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B138-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;138&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DeepChem&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Deep learning toolkit for drug discovery and cheminformatics&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://deepchem.io/&quot;&gt;https://deepchem.io/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B139-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;139&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;DR.PRODIS&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Prediction of drug-protein interactions, side effects &lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://cssb.biology.gatech.edu/repurpose&quot;&gt;http://cssb.biology.gatech.edu/repurpose&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B140-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;140&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;e-LEA3D&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Collection of tools related to computer-aided drug design&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://chemoinfo.ipmc.cnrs.fr/&quot;&gt;http://chemoinfo.ipmc.cnrs.fr/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B141-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;141&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Frog2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Chemo-informatics toolkit for small compound 3D generation from 1D/2D input&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://bioserv.rpbs.univ-paris-diderot.fr/services/Frog2/&quot;&gt;http://bioserv.rpbs.univ-paris-diderot.fr/services/Frog2/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B142-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;142&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GIFT&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Infer chemogenomic features from drug-target interactions.&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://bioinfo.au.tsinghua.edu.cn/software/GIFT/&quot;&gt;http://bioinfo.au.tsinghua.edu.cn/software/GIFT/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B143-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;143&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;GoPredict&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug target prioritization tool for breast and ovarian cancer&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://csblcanges.fimm.fi/GOPredict/&quot;&gt;http://csblcanges.fimm.fi/GOPredict/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B144-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;144&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;JOELib/JOELib2&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Toolkit to interconvert chemical file formats, descriptor calculation classes, and SMARTS substructure search&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.ra.cs.uni-tuebingen.de/software/joelib/introduction.html&quot;&gt;http://www.ra.cs.uni-tuebingen.de/software/joelib/introduction.html&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B145-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;145&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;ksRepo&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Drug repositioning tool that utilizes gene expression drug datasets from different platforms&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;https://github.com/adam-sam-brown/ksRepo&quot;&gt;https://github.com/adam-sam-brown/ksRepo&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B101-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;101&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;L1000CDS&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;L1000 dataset based gene expression signature search engine&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://amp.pharm.mssm.edu/L1000CDS2/#/index&quot;&gt;http://amp.pharm.mssm.edu/L1000CDS2/#/index&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B146-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;146&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;MANTRA&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Prediction and analysis of mechanism of action of drugs for drug repositioning&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://mantra.tigem.it/&quot;&gt;http://mantra.tigem.it/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B147-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;147&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;NFFinder&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Tool to discover multiple drugs with similar drugs based on up/down regulated genes&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://nffinder.cnb.csic.es/&quot;&gt;http://nffinder.cnb.csic.es/&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B102-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;102&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open babel&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open source chemistry toolbox&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://openbabel.org/wiki/Main_Page&quot;&gt;http://openbabel.org/wiki/Main_Page&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B148-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;148&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;Open PHACTS&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;European funded initiative to bring together industry and academic partners for semantic integration of pharmacological data using an RDF data model&lt;/td&gt;&lt;td align=&quot;left&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;
&lt;uri xlink:href=&quot;http://www.openphacts.org&quot;&gt;http://www.openphacts.org&lt;/uri&gt;
&lt;/td&gt;&lt;td align=&quot;center&quot; valign=&quot;middle&quot; style=&quot;border-bottom:solid thin&quot; rowspan=&quot;1&quot; colspan=&quot;1&quot;&gt;&lt;xref rid=&quot;B149-pharmaceuticals-11-00057&quot; ref-type=&quot;bibr&quot;&gt;149&lt;/xref&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>49785</offset><text>Tool	Description	URL	Ref	 	Clue	Tools for perturbagens (small molecules or genes) query, L1000 cohorts, and gene expression heatmap visualization			 	Clue Repurposing Tool	Interactive application to access approved and pre-clinical drug annotations			 	COGENA	Analysis, visualizing and clustering tool for gene expression profiles			 	DeepChem	Deep learning toolkit for drug discovery and cheminformatics			 	DR.PRODIS	Prediction of drug-protein interactions, side effects 			 	e-LEA3D	Collection of tools related to computer-aided drug design			 	Frog2	Chemo-informatics toolkit for small compound 3D generation from 1D/2D input			 	GIFT	Infer chemogenomic features from drug-target interactions.			 	GoPredict	Drug target prioritization tool for breast and ovarian cancer			 	JOELib/JOELib2	Toolkit to interconvert chemical file formats, descriptor calculation classes, and SMARTS substructure search			 	ksRepo	Drug repositioning tool that utilizes gene expression drug datasets from different platforms			 	L1000CDS	L1000 dataset based gene expression signature search engine			 	MANTRA	Prediction and analysis of mechanism of action of drugs for drug repositioning			 	NFFinder	Tool to discover multiple drugs with similar drugs based on up/down regulated genes			 	Open babel	Open source chemistry toolbox			 	Open PHACTS	European funded initiative to bring together industry and academic partners for semantic integration of pharmacological data using an RDF data model			 	</text></passage></document></collection>
